| DE635692C              (en) |  | 1936-09-22 | Herbert Zadow | Medical syringe | 
| US1655158A              (en) | 1926-09-08 | 1928-01-03 | Radium Emanation Corp | Instrument for implanting radon seeds | 
| FR640907A              (en) | 1927-06-25 | 1928-07-24 |  | Automatic flow limiter | 
| US2168437A              (en) | 1935-04-10 | 1939-08-08 | Kenneth O Buercklin | Injection device | 
| US2110208A              (en) | 1937-02-12 | 1938-03-08 | U S Standard Products Company | Antigen preparations | 
| US2531724A              (en)* | 1948-09-20 | 1950-11-28 | Edmund D Cevasco | Infant bath mat | 
| US2643653A              (en) | 1951-07-19 | 1953-06-30 | Heidrich John | Pill injector | 
| US3016895A              (en) | 1958-08-01 | 1962-01-16 | Pan American Lab Inc | Injector for subcutaneous implantation of solids | 
| US3025991A              (en) | 1960-05-23 | 1962-03-20 | Carron Products Co | Bottle stopper | 
| US3523906A              (en) | 1962-07-11 | 1970-08-11 | Gevaert Photo Prod Nv | Process for encapsulating water and compounds in aqueous phase by evaporation | 
| GB1049104A              (en) | 1963-05-11 | 1966-11-23 | Prodotti Antibiotici Spa | Pharmaceutical compositions for oral or parenteral administration comprising tetracycline antibiotics | 
| US3122162A              (en) | 1963-06-20 | 1964-02-25 | Asa D Sands | Flow control device | 
| US3538916A              (en) | 1968-12-19 | 1970-11-10 | Joseph S Wiles | Injection pistol | 
| US3691090A              (en) | 1969-01-16 | 1972-09-12 | Fuji Photo Film Co Ltd | Encapsulation method | 
| US3620216A              (en) | 1969-06-25 | 1971-11-16 | Abbott Lab | Implant trocar | 
| US3632768A              (en) | 1969-10-02 | 1972-01-04 | Upjohn Co | Therapeutic composition and method for treating infections with actinospectacin | 
| US3773919A              (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures | 
| US3737337A              (en) | 1970-03-04 | 1973-06-05 | Bayer Ag | Process for the production of microgranulates | 
| US3625214A              (en) | 1970-05-18 | 1971-12-07 | Alza Corp | Drug-delivery device | 
| US3669104A              (en) | 1970-06-15 | 1972-06-13 | Pfizer | Implant gun | 
| US3732865A              (en) | 1971-01-13 | 1973-05-15 | Alza Corp | Osmotic dispenser | 
| US3995631A              (en) | 1971-01-13 | 1976-12-07 | Alza Corporation | Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient | 
| US4034756A              (en) | 1971-01-13 | 1977-07-12 | Alza Corporation | Osmotically driven fluid dispenser | 
| US4211771A              (en) | 1971-06-01 | 1980-07-08 | Robins Ronald K | Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide | 
| US3766915A              (en) | 1971-12-21 | 1973-10-23 | Illinois Tool Works | Plastic needle holder | 
| US3891570A              (en) | 1972-01-26 | 1975-06-24 | Toyo Jozo Kk | Process for preparing microcapsules | 
| US3869549A              (en) | 1972-02-17 | 1975-03-04 | Ciba Geigy Corp | Injectable oily peptide preparations and processes for their manufacture | 
| US3797492A              (en) | 1972-12-27 | 1974-03-19 | Alza Corp | Device for dispensing product with directional guidance member | 
| US3995632A              (en) | 1973-05-04 | 1976-12-07 | Alza Corporation | Osmotic dispenser | 
| US3960757A              (en) | 1973-06-27 | 1976-06-01 | Toyo Jozo Co., Ltd. | Process for encapsulation of medicaments | 
| GB1518683A              (en) | 1974-07-05 | 1978-07-19 | Sandoz Ltd | Pharmaceutical compositions | 
| US4221862A              (en) | 1975-06-27 | 1980-09-09 | Fuji Photo Film Co., Ltd. | Method of producing finely divided polymer particles | 
| US3987790A              (en) | 1975-10-01 | 1976-10-26 | Alza Corporation | Osmotically driven fluid dispenser | 
| US4008719A              (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent | 
| US4078060A              (en) | 1976-05-10 | 1978-03-07 | Richardson-Merrell Inc. | Method of inducing an estrogenic response | 
| US4203439A              (en) | 1976-11-22 | 1980-05-20 | Alza Corporation | Osmotic system with volume amplifier for increasing amount of agent delivered therefrom | 
| US4111201A              (en) | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for delivering selected beneficial agents having varying degrees of solubility | 
| US4111203A              (en) | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system with means for improving delivery kinetics of system | 
| US4111202A              (en) | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for the controlled and delivery of agent over time | 
| US4105030A              (en) | 1977-01-03 | 1978-08-08 | Syntex (U.S.A.) Inc. | Implant apparatus | 
| USD258837S              (en) | 1977-10-17 | 1981-04-07 | Gambro Dialysatoren Gmbh And Co. Kg | Dialyzer cartridge | 
| USD259458S              (en)* | 1978-06-09 | 1981-06-09 | Fuller Charles R | Support pad for an infant | 
| US4223674A              (en) | 1978-06-29 | 1980-09-23 | Arthur J. McIntosh | Implant gun | 
| US4243030A              (en) | 1978-08-18 | 1981-01-06 | Massachusetts Institute Of Technology | Implantable programmed microinfusion apparatus | 
| US4305927A              (en) | 1979-02-05 | 1981-12-15 | Alza Corporation | Method for the management of intraocular pressure | 
| US4373527B1              (en) | 1979-04-27 | 1995-06-27 | Univ Johns Hopkins | Implantable programmable medication infusion system | 
| US4373527A              (en) | 1979-04-27 | 1983-02-15 | The Johns Hopkins University | Implantable, programmable medication infusion system | 
| US4310516A              (en) | 1980-02-01 | 1982-01-12 | Block Drug Company Inc. | Cosmetic and pharmaceutical vehicle thickened with solid emulsifier | 
| US4384975A              (en) | 1980-06-13 | 1983-05-24 | Sandoz, Inc. | Process for preparation of microspheres | 
| EP0079405A1              (en) | 1980-07-23 | 1983-05-25 | Corless, Marion | Apparatus for improving blood sugar control in diabetics | 
| US4350271A              (en) | 1980-08-22 | 1982-09-21 | Alza Corporation | Water absorbing fluid dispenser | 
| US4376118A              (en) | 1980-10-06 | 1983-03-08 | Miles Laboratories, Inc. | Stable nonaqueous solution of tetracycline salt | 
| US4389330A              (en) | 1980-10-06 | 1983-06-21 | Stolle Research And Development Corporation | Microencapsulation process | 
| US4451253A              (en) | 1980-12-18 | 1984-05-29 | Harman Sherman M | Means and method for administering medicinals | 
| US4340054A              (en) | 1980-12-29 | 1982-07-20 | Alza Corporation | Dispenser for delivering fluids and solids | 
| US4444498A              (en)* | 1981-02-27 | 1984-04-24 | Bentley Laboratories | Apparatus and method for measuring blood oxygen saturation | 
| US4455145A              (en) | 1981-07-10 | 1984-06-19 | Alza Corporation | Dispensing device with internal drive | 
| USD271990S              (en)* | 1981-09-17 | 1983-12-27 | Arthur W. Pulfer | Baby bath | 
| US4474572A              (en) | 1981-09-29 | 1984-10-02 | Syntex (U.S.A.) Inc. | Implanting device and implant magazine | 
| US4882166A              (en) | 1981-09-30 | 1989-11-21 | National Research Development Corporation | Compositions comprising encapsulated particles and their preparation | 
| US4727138A              (en) | 1981-10-19 | 1988-02-23 | Genentech, Inc. | Human immune interferon | 
| US4762791A              (en) | 1981-10-19 | 1988-08-09 | Genentech, Inc. | Human immune interferon | 
| US4929554A              (en) | 1981-10-19 | 1990-05-29 | Goeddel David V | Human immune interferon | 
| US4588614A              (en) | 1981-10-20 | 1986-05-13 | Adnovum Ag | Pseudoplastic gel transfer | 
| US4675184A              (en) | 1981-11-28 | 1987-06-23 | 501 Sunstar Kabushiki Kaisha | Pharmaceutical composition containing interferon in stable state | 
| US5004689A              (en) | 1982-02-22 | 1991-04-02 | Biogen, Massachusetts | DNA sequences, recombinant DNA molecules and processes for producing human gamma interferon-like polypeptides in high yields | 
| US4439196A              (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system | 
| US4455143A              (en) | 1982-03-22 | 1984-06-19 | Alza Corporation | Osmotic device for dispensing two different medications | 
| US4897471A              (en) | 1982-05-06 | 1990-01-30 | Amgen | Consensus human leukocyte interferon | 
| US4695623A              (en) | 1982-05-06 | 1987-09-22 | Amgen | Consensus human leukocyte interferon | 
| US4820638A              (en) | 1982-05-28 | 1989-04-11 | Dr. Karl Thomae Gmbh | Novel alpha interferon species produced by recombinant means | 
| US4530840A              (en) | 1982-07-29 | 1985-07-23 | The Stolle Research And Development Corporation | Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents | 
| US4753651A              (en) | 1982-08-30 | 1988-06-28 | Alza Corporation | Self-driven pump | 
| US5795779A              (en) | 1982-11-01 | 1998-08-18 | Berlex Laboratories, Inc. | Human interferon-β (IFN-β) produced in Chinese hamster ovary (CHO) cells | 
| US4552561A              (en) | 1982-12-23 | 1985-11-12 | Alza Corporation | Body mounted pump housing and pump assembly employing the same | 
| US4673405A              (en) | 1983-03-04 | 1987-06-16 | Alza Corporation | Osmotic system with instant drug availability | 
| US4597753A              (en) | 1983-04-21 | 1986-07-01 | Hundon Forge Limited | Implanting method and device | 
| GB2138298B              (en) | 1983-04-21 | 1986-11-05 | Hundon Forge Ltd | Pellet implanter | 
| US4639244A              (en) | 1983-05-03 | 1987-01-27 | Nabil I. Rizk | Implantable electrophoretic pump for ionic drugs and associated methods | 
| US4765989A              (en) | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs | 
| US4783337A              (en) | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug | 
| US4873080A              (en) | 1983-06-08 | 1989-10-10 | Dr. Karl Thomae Gmbh | Oral anti-diabetic pharmaceutical compositions and the preparation thereof | 
| US4743449A              (en) | 1983-09-12 | 1988-05-10 | Fujisawa Pharmaceutical Co., Ltd. | Drug-containing lipid vesicle preparation and method for preparing them | 
| US4594108A              (en) | 1983-09-19 | 1986-06-10 | The Dow Chemical Company | Highly pseudoplastic polymer solutions | 
| US5385738A              (en) | 1983-10-14 | 1995-01-31 | Sumitomo Pharmaceuticals Company, Ltd. | Sustained-release injection | 
| US4923805A              (en) | 1983-11-02 | 1990-05-08 | Integrated Genetics, Inc. | Fsh | 
| US5639640A              (en) | 1983-11-02 | 1997-06-17 | Genzyme Corporation | DNA encoding the beta subunit of human follide stimulating hormone and expression vectors and cells containing same | 
| US5767251A              (en) | 1983-11-02 | 1998-06-16 | Genzyme Corporation | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof | 
| US4840896A              (en) | 1983-11-02 | 1989-06-20 | Integrated Genetics, Inc. | Heteropolymeric protein | 
| US5574137A              (en) | 1983-12-16 | 1996-11-12 | Genentech, Inc. | Recombinant gamma interferons having enhanced stability and methods therefor | 
| US5690925A              (en) | 1983-12-16 | 1997-11-25 | Genentech, Inc. | Recombinant gamma interferons having enhanced stability and methods therefor | 
| US4851228A              (en) | 1984-06-20 | 1989-07-25 | Merck & Co., Inc. | Multiparticulate controlled porosity osmotic | 
| US5120832A              (en) | 1984-08-27 | 1992-06-09 | Genentech, Inc. | Distinct family of human leukocyte interferons | 
| US5231176A              (en) | 1984-08-27 | 1993-07-27 | Genentech, Inc. | Distinct family DNA encoding of human leukocyte interferons | 
| US4927687A              (en) | 1984-10-01 | 1990-05-22 | Biotek, Inc. | Sustained release transdermal drug delivery composition | 
| US5411951A              (en) | 1984-10-04 | 1995-05-02 | Monsanto Company | Prolonged release of biologically active somatotropin | 
| US4940588A              (en) | 1984-10-30 | 1990-07-10 | Elan Corporation | Controlled release powder and process for its preparation | 
| US4952402A              (en) | 1984-10-30 | 1990-08-28 | Elan Corporation, P.L.C. | Controlled release powder and process for its preparation | 
| US5605688A              (en) | 1984-12-18 | 1997-02-25 | Boehringer Ingelheim International Gmbh | Recombinant dog and horse type I interferons | 
| US4655462A              (en) | 1985-01-07 | 1987-04-07 | Peter J. Balsells | Canted coiled spring and seal | 
| EP0521586A1              (en) | 1985-01-30 | 1993-01-07 | Applied Research Systems ARS Holding N.V. | FSH and other recombinant hormones | 
| US4734284A              (en) | 1985-02-19 | 1988-03-29 | Nippon Kayaku Kabushiki Kaisha | Etoposide preparations | 
| US4820267A              (en) | 1985-02-19 | 1989-04-11 | Endocon, Inc. | Cartridge injector for pellet medicaments | 
| US4609374A              (en) | 1985-04-22 | 1986-09-02 | Alza Corporation | Osmotic device comprising means for governing initial time of agent release therefrom | 
| US4885166A              (en) | 1985-06-11 | 1989-12-05 | Ciba-Geigy Corporation | Hybrid interferons | 
| US4845196A              (en) | 1985-06-24 | 1989-07-04 | G. D. Searle & Co. | Modified interferon gammas | 
| US4847079A              (en) | 1985-07-29 | 1989-07-11 | Schering Corporation | Biologically stable interferon compositions comprising thimerosal | 
| US4818517A              (en) | 1986-01-24 | 1989-04-04 | Akzo N.V. | Pharmaceutical preparation for obtaining a highly viscose hydrogel or suspension | 
| US4917887A              (en) | 1986-03-10 | 1990-04-17 | Boehringer Ingelheim International Gmbh | Hybrid interferons, their use as pharmaceutical compositions and as intermediate products for the preparation of antibodies and the use thereof and processes for preparing them | 
| US4865845A              (en) | 1986-03-21 | 1989-09-12 | Alza Corporation | Release rate adjustment of osmotic or diffusional delivery devices | 
| US4737437A              (en) | 1986-03-27 | 1988-04-12 | East Shore Chemical Co. | Light sensitive diazo compound, composition and method of making the composition | 
| US5118666A              (en) | 1986-05-05 | 1992-06-02 | The General Hospital Corporation | Insulinotropic hormone | 
| US5958909A              (en) | 1986-05-05 | 1999-09-28 | The General Hospital Corporation | Insulinotropic hormones and uses thereof | 
| US7138486B2              (en) | 1986-05-05 | 2006-11-21 | The General Hospital Corporation | Insulinotropic hormone derivatives and uses thereof | 
| US5614492A              (en) | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof | 
| US6849708B1              (en) | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof | 
| US5120712A              (en) | 1986-05-05 | 1992-06-09 | The General Hospital Corporation | Insulinotropic hormone | 
| EP0254394A1              (en) | 1986-06-16 | 1988-01-27 | Alza Corporation | Dosage form for delivering a drug comprising solubility regulating member | 
| US5071642A              (en) | 1986-10-23 | 1991-12-10 | Dr. Rentschler Arzneimittel Gmbh & Co. | Dihydropyridine containing compositions | 
| US6372218B1              (en) | 1986-11-06 | 2002-04-16 | The Texas A&M University System | Interferon dosage form and method therefor | 
| US5019382A              (en) | 1986-11-06 | 1991-05-28 | The Texas A&M University System | Treatment of immuno-resistant disease with low-dose interferon | 
| US5602010A              (en) | 1986-12-10 | 1997-02-11 | Boehringer Ingelheim International Gmbh | DNA encoding equine-gamma interferon and recombinant production of equine IFN-γ polypeptides | 
| US4871094A              (en) | 1986-12-31 | 1989-10-03 | Alcon Laboratories, Inc. | Means and method for dispensing substances | 
| US5371089A              (en) | 1987-02-26 | 1994-12-06 | Senetek, Plc | Method and composition for ameliorating the adverse effects of aging | 
| FR2616665A2              (en) | 1987-03-16 | 1988-12-23 | Denance Raymond | Stabiliser adaptor for hypodermic needle, for adjusting penetration as a function of the angle of attack, formed from a needle guard | 
| US4994028A              (en) | 1987-03-18 | 1991-02-19 | Endocon, Inc. | Injector for inplanting multiple pellet medicaments | 
| US4834708A              (en) | 1987-03-31 | 1989-05-30 | George Pillari | Puncture needle assembly | 
| US5278151A              (en) | 1987-04-02 | 1994-01-11 | Ocular Research Of Boston, Inc. | Dry eye treatment solution | 
| EP0295411A1              (en) | 1987-05-15 | 1988-12-21 | Sansho Co., Ltd. | Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or a salt thereof | 
| US4940465A              (en) | 1987-05-27 | 1990-07-10 | Felix Theeuwes | Dispenser comprising displaceable matrix with solid state properties | 
| US4892778A              (en) | 1987-05-27 | 1990-01-09 | Alza Corporation | Juxtaposed laminated arrangement | 
| US4874388A              (en) | 1987-06-25 | 1989-10-17 | Alza Corporation | Multi-layer delivery system | 
| US5938654A              (en) | 1987-06-25 | 1999-08-17 | Alza Corporation | Osmotic device for delayed delivery of agent | 
| US5023088A              (en) | 1987-06-25 | 1991-06-11 | Alza Corporation | Multi-unit delivery system | 
| US4915949A              (en) | 1987-07-13 | 1990-04-10 | Alza Corporation | Dispenser with movable matrix comprising a plurality of tiny pills | 
| US4957119A              (en) | 1987-08-08 | 1990-09-18 | Akzo N.V. | Contraceptive implant | 
| EP0304107A1              (en) | 1987-08-18 | 1989-02-22 | Akzo N.V. | Implant injection device | 
| US4915954A              (en) | 1987-09-03 | 1990-04-10 | Alza Corporation | Dosage form for delivering a drug at two different rates | 
| US5756450A              (en) | 1987-09-15 | 1998-05-26 | Novartis Corporation | Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms | 
| US4886668A              (en) | 1987-09-24 | 1989-12-12 | Merck & Co., Inc. | Multiparticulate controlled porosity osmotic pump | 
| US5204108A              (en) | 1987-10-10 | 1993-04-20 | Danbiosyst Uk Ltd. | Transmucosal formulations of low molecular weight peptide drugs | 
| WO1989003678A1              (en) | 1987-10-30 | 1989-05-05 | Stolle Research & Development Corporation | Low residual solvent microspheres and microencapsulation process | 
| US4917895A              (en) | 1987-11-02 | 1990-04-17 | Alza Corporation | Transdermal drug delivery device | 
| US4974821A              (en) | 1988-04-25 | 1990-12-04 | Peter J. Balsells | Canted-coil spring with major axis radial loading | 
| US5117066A              (en) | 1988-04-25 | 1992-05-26 | Peter J. Balsells | Retaining and locking electromagnetic gasket | 
| US4876781A              (en) | 1988-04-25 | 1989-10-31 | Peter J. Balsells | Method of making a garter-type axially resilient coiled spring | 
| US4907788A              (en) | 1988-04-25 | 1990-03-13 | Peter J. Balsells | Dual concentric canted-coil spring apparatus | 
| US5134244A              (en) | 1988-04-25 | 1992-07-28 | Peter J. Balsells | Electromagnetic shielding seal for rotary/reciprocating shaft | 
| US4915366A              (en) | 1988-04-25 | 1990-04-10 | Peter J. Balsells | Outside back angle canted coil spring | 
| US4830344A              (en) | 1988-04-25 | 1989-05-16 | Peter J. Balsells | Canted-coil spring with turn angle and seal | 
| US4934666A              (en) | 1988-04-25 | 1990-06-19 | Peter J. Balsells | Coiled spring electromagnetic shielding gasket | 
| US4826144A              (en) | 1988-04-25 | 1989-05-02 | Peter J. Balsells | Inside back angle canted coil spring | 
| US4961253A              (en) | 1988-04-25 | 1990-10-09 | Peter J. Balsells | Manufacturing method for canted-coil spring with turn angle and seal | 
| US4964204A              (en) | 1988-04-25 | 1990-10-23 | Peter J. Balsells | Method for making a garter-type axially-resilient coil spring | 
| US5108078A              (en) | 1988-04-25 | 1992-04-28 | Peter J. Balsells | Canted-coil spring loaded while in a cavity | 
| US4931285A              (en) | 1988-04-28 | 1990-06-05 | Alza Corporation | Aqueous based pharmaceutical coating composition for dosage forms | 
| US5024842A              (en) | 1988-04-28 | 1991-06-18 | Alza Corporation | Annealed coats | 
| US5160743A              (en) | 1988-04-28 | 1992-11-03 | Alza Corporation | Annealed composition for pharmaceutically acceptable drug | 
| US5006346A              (en) | 1988-04-28 | 1991-04-09 | Alza Corporation | Delivery system | 
| JPH02124814A              (en) | 1988-07-05 | 1990-05-14 | Takeda Chem Ind Ltd | Sustained release microcapsule containing water-soluble drug | 
| US4893795A              (en) | 1988-08-15 | 1990-01-16 | Peter J. Balsells | Radially loaded canted coiled spring with turn angle | 
| EP0368339A2              (en) | 1988-11-11 | 1990-05-16 | Eisai Co., Ltd. | Pharmaceutical preparation for percutaneous administration containing bunazosin or its salt | 
| US5728088A              (en) | 1988-12-13 | 1998-03-17 | Alza Corporation | Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals | 
| EP0373867A1              (en) | 1988-12-13 | 1990-06-20 | Alza Corporation | Delivery system comprising means for governing fluid ingress into the system | 
| US5110596A              (en) | 1988-12-13 | 1992-05-05 | Alza Corporation | Delivery system comprising means for delivering agent to livestock | 
| US5320616A              (en) | 1988-12-13 | 1994-06-14 | Alza Corporation | Delivery system comprising first walled section and second walled section united by fusion, adhesion or telescopic engagement | 
| US5034229A              (en) | 1988-12-13 | 1991-07-23 | Alza Corporation | Dispenser for increasing feed conversion of hog | 
| US5059423A              (en) | 1988-12-13 | 1991-10-22 | Alza Corporation | Delivery system comprising biocompatible beneficial agent formulation | 
| US5057318A              (en) | 1988-12-13 | 1991-10-15 | Alza Corporation | Delivery system for beneficial agent over a broad range of rates | 
| US5234424A              (en) | 1988-12-28 | 1993-08-10 | Alza Corporation | Osmotically driven syringe | 
| US4969884A              (en) | 1988-12-28 | 1990-11-13 | Alza Corporation | Osmotically driven syringe | 
| US4976966A              (en) | 1988-12-29 | 1990-12-11 | Alza Corporation | Delayed release osmotically driven fluid dispenser | 
| US5066436A              (en) | 1989-01-04 | 1991-11-19 | Gist-Brocades N.V. | Process for microencapsulation | 
| EP0379147B1              (en) | 1989-01-17 | 1994-09-28 | Sterling Winthrop Inc. | Extrudable elastic gel for use as carrier for therapeutic agent | 
| US5738845A              (en) | 1989-03-02 | 1998-04-14 | The Women's Research Institute | Human interferon τ proteins and methods of use | 
| US5942223A              (en) | 1989-03-02 | 1999-08-24 | University Of Florida | Antiviral therapy using ovine or bovine interferon-tau | 
| US5219572A              (en) | 1989-03-17 | 1993-06-15 | Pitman-Moore, Inc. | Controlled release delivery device for macromolecular proteins | 
| NL8901004A              (en) | 1989-04-21 | 1990-11-16 | Nedap Nv | Positioning attachment for animal implanting or injecting tool - has automatically shaped transparent positioning piece with adjustable needle insertion depth | 
| NL9000948A              (en) | 1989-04-21 | 1990-11-16 | Nedap Nv | Injection and implanting instrument for coding or numbering animals - has handle sliding on guide pin with insertion depth stop parallel to hollow needle and anatomically shaped locating plate | 
| US5090962A              (en) | 1989-04-28 | 1992-02-25 | Flp Enterprises, Inc. | Non-reusable syringe | 
| WO1990013285A1              (en) | 1989-05-01 | 1990-11-15 | Enzytech, Inc. | Process for producing small particles of biologically active molecules | 
| WO1990013780A1              (en) | 1989-05-01 | 1990-11-15 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres | 
| US5019400A              (en) | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres | 
| WO1990013361A1              (en) | 1989-05-04 | 1990-11-15 | Southern Research Institute | Improved encapsulation process and products therefrom | 
| US5407609A              (en) | 1989-05-04 | 1995-04-18 | Southern Research Institute | Microencapsulation process and products therefrom | 
| US5445829A              (en) | 1989-05-05 | 1995-08-29 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations | 
| US5126142A              (en) | 1989-07-18 | 1992-06-30 | Alza Corporation | Dispenser comprising ionophore | 
| US5192273A              (en) | 1989-07-24 | 1993-03-09 | Steven F. Bierman | Catheterization system | 
| US5225205A              (en) | 1989-07-28 | 1993-07-06 | Debiopharm S.A. | Pharmaceutical composition in the form of microparticles | 
| US5439688A              (en) | 1989-07-28 | 1995-08-08 | Debio Recherche Pharmaceutique S.A. | Process for preparing a pharmaceutical composition | 
| US5336505A              (en) | 1989-08-28 | 1994-08-09 | Pharmaceutical Delivery Systems | Bioerodible polymers useful for the controlled release of therapeutic agents | 
| US5660847A              (en) | 1989-09-14 | 1997-08-26 | Alza Corporation | Implantable delivery dispenser comprising exit port | 
| US5112614A              (en) | 1989-09-14 | 1992-05-12 | Alza Corporation | Implantable delivery dispenser | 
| US5284655A              (en) | 1989-09-21 | 1994-02-08 | Osteotech, Inc. | Swollen demineralized bone particles, flowable osteogenic composition containing same and use of the composition in the repair of osseous defects | 
| US5614221A              (en) | 1989-10-23 | 1997-03-25 | Medivent | Method of preparing a drug delivery system comprising a drug and a gel using a syringe | 
| US5707644A              (en) | 1989-11-04 | 1998-01-13 | Danbiosyst Uk Limited | Small particle compositions for intranasal drug delivery | 
| US5312335A              (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device | 
| WO1991007160A1              (en) | 1989-11-13 | 1991-05-30 | Medicorp Holding S.A. | Storage bottle containing a constituent of a medicinal solution | 
| US5079388A              (en) | 1989-12-01 | 1992-01-07 | Peter J. Balsells | Gasket for sealing electromagnetic waves | 
| US5072070A              (en) | 1989-12-01 | 1991-12-10 | Peter J. Balsells | Device for sealing electromagnetic waves | 
| EP0431942A2              (en) | 1989-12-06 | 1991-06-12 | Sansho Co., Ltd. | Percutaneously absorbable pharmaceutical preparation containing dopamine derivative | 
| US5030216A              (en) | 1989-12-15 | 1991-07-09 | Alza Corporation | Osmotically driven syringe | 
| US5733572A              (en) | 1989-12-22 | 1998-03-31 | Imarx Pharmaceutical Corp. | Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles | 
| USD326718S              (en) | 1989-12-26 | 1992-06-02 | Minnesota Mining And Manufacturing Co. | Blood sensor cassette | 
| US5545618A              (en) | 1990-01-24 | 1996-08-13 | Buckley; Douglas I. | GLP-1 analogs useful for diabetes treatment | 
| US5368863A              (en) | 1990-01-24 | 1994-11-29 | Alza Corporation | Long-term delivery device with early startup | 
| US5213809A              (en) | 1990-01-24 | 1993-05-25 | Alza Corporation | Delivery system comprising means for controlling internal pressure | 
| US5053014A              (en) | 1990-02-01 | 1991-10-01 | Critikon, Inc. | Catheter with controlled valve | 
| US5126147A              (en) | 1990-02-08 | 1992-06-30 | Biosearch, Inc. | Sustained release dosage form | 
| US5279554A              (en) | 1990-02-09 | 1994-01-18 | Rhone Merieux | Implanting device | 
| US5478564A              (en) | 1990-02-22 | 1995-12-26 | Teva Pharmaceutical Industries, Ltd. | Preparation of microparticles for controlled release of water-soluble substances | 
| US5122128A              (en) | 1990-03-15 | 1992-06-16 | Alza Corporation | Orifice insert for a ruminal bolus | 
| US5160122A              (en) | 1990-03-20 | 1992-11-03 | Peter J. Balsells | Coil spring with an elastomer having a hollow coil cross section | 
| US5203849A              (en) | 1990-03-20 | 1993-04-20 | Balsells Peter J | Canted coil spring in length filled with an elastomer | 
| US5120306A              (en) | 1990-03-21 | 1992-06-09 | Gosselin Leon F | Direct delivery of anti-inflammatories to the proximal small bowel | 
| US5213810A              (en) | 1990-03-30 | 1993-05-25 | American Cyanamid Company | Stable compositions for parenteral administration and method of making same | 
| US5207752A              (en) | 1990-03-30 | 1993-05-04 | Alza Corporation | Iontophoretic drug delivery system with two-stage delivery profile | 
| US5324280A              (en) | 1990-04-02 | 1994-06-28 | Alza Corporation | Osmotic dosage system for delivering a formulation comprising liquid carrier and drug | 
| US5413572A              (en) | 1990-04-02 | 1995-05-09 | Alza Corporation | Osmotic dosage system for liquid drug delivery | 
| US5091188A              (en) | 1990-04-26 | 1992-02-25 | Haynes Duncan H | Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs | 
| US5290271A              (en) | 1990-05-14 | 1994-03-01 | Jernberg Gary R | Surgical implant and method for controlled release of chemotherapeutic agents | 
| US5374620A              (en) | 1990-06-07 | 1994-12-20 | Genentech, Inc. | Growth-promoting composition and its use | 
| US5234693A              (en) | 1990-07-11 | 1993-08-10 | Alza Corporation | Delivery device with a protective sleeve | 
| US5180591A              (en) | 1990-07-11 | 1993-01-19 | Alza Corporation | Delivery device with a protective sleeve | 
| US5234692A              (en) | 1990-07-11 | 1993-08-10 | Alza Corporation | Delivery device with a protective sleeve | 
| US5234695A              (en) | 1990-07-24 | 1993-08-10 | Eastman Kodak Company | Water dispersible vitamin E composition | 
| US7008439B1              (en) | 1990-09-21 | 2006-03-07 | Datascope Investments Corp. | Device and method for sealing puncture wounds | 
| USD329278S              (en)* | 1990-10-01 | 1992-09-08 | Gallup Allen I | Infant's bathing support | 
| US5300302A              (en) | 1990-10-04 | 1994-04-05 | Nestec S.A. | Pharmaceutical composition in gel form in a dispensing package | 
| US5529914A              (en) | 1990-10-15 | 1996-06-25 | The Board Of Regents The Univeristy Of Texas System | Gels for encapsulation of biological materials | 
| US5312389A              (en) | 1990-10-29 | 1994-05-17 | Felix Theeuwes | Osmotically driven syringe with programmable agent delivery | 
| US5151093A              (en) | 1990-10-29 | 1992-09-29 | Alza Corporation | Osmotically driven syringe with programmable agent delivery | 
| US5122377A              (en) | 1990-11-19 | 1992-06-16 | A.H. Robins, Company, Incorporated | Oral delivery system for veterinary drugs | 
| EP0486959A1              (en) | 1990-11-22 | 1992-05-27 | Vectorpharma International S.P.A. | Pharmaceutical composition of microparticles with controlled release and process of preparing it | 
| US5700486A              (en) | 1990-11-22 | 1997-12-23 | Vectorpharma International S.P.A. | Pharmaceutical compositions in the form of particles suitable for the controlled release of pharmacologically active substances and process for preparing the same compositions | 
| US5279544A              (en) | 1990-12-13 | 1994-01-18 | Sil Medics Ltd. | Transdermal or interdermal drug delivery devices | 
| US5161806A              (en) | 1990-12-17 | 1992-11-10 | Peter J. Balsells | Spring-loaded, hollow, elliptical ring seal | 
| US5279608A              (en) | 1990-12-18 | 1994-01-18 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Osmotic pumps | 
| US5543156A              (en) | 1991-01-09 | 1996-08-06 | Alza Corporation | Bioerodible devices and compositions for diffusional release of agents | 
| US5147295A              (en) | 1991-01-23 | 1992-09-15 | Ideal Instruments, Inc. | Retractable implanter | 
| US5300079A              (en) | 1991-01-30 | 1994-04-05 | Texas Instruments Incorporated | Injector | 
| US5531736A              (en) | 1991-01-30 | 1996-07-02 | Alza Corporation | Osmotic device for delayed delivery of agent | 
| NL9100160A              (en) | 1991-01-30 | 1992-08-17 | Texas Instruments Holland | INJECTOR. | 
| EP0497575A1              (en) | 1991-01-30 | 1992-08-05 | Texas Instruments Holland B.V. | Injector | 
| US5443459A              (en) | 1991-01-30 | 1995-08-22 | Alza Corporation | Osmotic device for delayed delivery of agent | 
| US5395319A              (en) | 1991-03-06 | 1995-03-07 | Suddeutsche Feinmechanik Gmbh | Needle for inserting an object into the body | 
| US5861166A              (en) | 1991-03-12 | 1999-01-19 | Alza Corporation | Delivery device providing beneficial agent stability | 
| WO1992019241A1              (en) | 1991-05-07 | 1992-11-12 | Dynagen, Inc. | A controlled, sustained release delivery system for smoking cessation | 
| US5113938A              (en) | 1991-05-07 | 1992-05-19 | Clayton Charley H | Whipstock | 
| US5137727A              (en) | 1991-06-12 | 1992-08-11 | Alza Corporation | Delivery device providing beneficial agent stability | 
| US5711967A              (en) | 1991-06-17 | 1998-01-27 | Spirig Ag, Pharmazeutische Praeparate | Oral diclofenac preparation | 
| US5252338A              (en) | 1991-06-27 | 1993-10-12 | Alza Corporation | Therapy delayed | 
| US5190765A              (en) | 1991-06-27 | 1993-03-02 | Alza Corporation | Therapy delayed | 
| US5541172A              (en) | 1991-06-28 | 1996-07-30 | Endorecherche, Inc. | Controlled release systems and low dose androgens | 
| US5288501A              (en) | 1991-07-04 | 1994-02-22 | Merz + Co. Gmbh & Co. | Mechanically-stable, readily-disintegratable tablets made of small preformed particles containing active ingredients | 
| US5336057A              (en) | 1991-09-30 | 1994-08-09 | Nippon Densan Corporation | Micropump with liquid-absorptive polymer gel actuator | 
| US5352662A              (en) | 1991-10-01 | 1994-10-04 | Brooks Norman D | Injectable extended release formulations and methods | 
| WO1993006821A1              (en) | 1991-10-04 | 1993-04-15 | Yoshitomi Pharmaceutical Industries, Ltd. | Sustained-release tablet | 
| WO1993006819A1              (en) | 1991-10-10 | 1993-04-15 | Alza Corporation | Osmotic drug delivery devices with hydrophobic wall materials | 
| US5795591A              (en) | 1991-10-10 | 1998-08-18 | Alza Corporation | Osmotic drug delivery devices with hydrophobic wall materials | 
| US5288502A              (en) | 1991-10-16 | 1994-02-22 | The University Of Texas System | Preparation and uses of multi-phase microspheres | 
| US5318780A              (en) | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels | 
| WO1993008832A1              (en) | 1991-11-08 | 1993-05-13 | Dallas Biotherapeutics, Inc. | Stabilization of human interferon | 
| WO1993009763A1              (en) | 1991-11-15 | 1993-05-27 | Isp Investments Inc. | Pharmaceutical tablet with pvp having an enhanced drug dissolution rate | 
| US5511355A              (en) | 1991-11-15 | 1996-04-30 | Dingler; Gerhard | Construction element | 
| US5830501A              (en) | 1991-12-06 | 1998-11-03 | Alza Corporation | Dosage form comprising hydrophilic polymer | 
| US5223265A              (en) | 1992-01-10 | 1993-06-29 | Alza Corporation | Osmotic device with delayed activation of drug delivery | 
| US5312390A              (en) | 1992-01-10 | 1994-05-17 | Alza Corporation | Osmotic device with delayed activation of drug delivery | 
| US5658593A              (en) | 1992-01-16 | 1997-08-19 | Coletica | Injectable compositions containing collagen microcapsules | 
| US5580578A              (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers | 
| US5676942A              (en) | 1992-02-10 | 1997-10-14 | Interferon Sciences, Inc. | Composition containing human alpha interferon species proteins and method for use thereof | 
| US5209746A              (en) | 1992-02-18 | 1993-05-11 | Alza Corporation | Osmotically driven delivery devices with pulsatile effect | 
| US5308348A              (en) | 1992-02-18 | 1994-05-03 | Alza Corporation | Delivery devices with pulsatile effect | 
| US5456679A              (en) | 1992-02-18 | 1995-10-10 | Alza Corporation | Delivery devices with pulsatile effect | 
| US5428024A              (en) | 1992-02-28 | 1995-06-27 | Collagen Corporation | High concentration homogenized collagen compositions | 
| US5656297A              (en) | 1992-03-12 | 1997-08-12 | Alkermes Controlled Therapeutics, Incorporated | Modulated release from biocompatible polymers | 
| US5318558A              (en) | 1992-03-12 | 1994-06-07 | Alza Corporation | Osmotically driven delivery device with expandable orifice for pulsatile delivery effect | 
| US5221278A              (en) | 1992-03-12 | 1993-06-22 | Alza Corporation | Osmotically driven delivery device with expandable orifice for pulsatile delivery effect | 
| US5540912A              (en) | 1992-03-30 | 1996-07-30 | Alza Corporation | Viscous suspensions of controlled-release drug particles | 
| US5571525A              (en) | 1992-03-30 | 1996-11-05 | Alza Corporation | Erosion rate modifier for use in bioerodible drug delivery devices and method of use | 
| US5858746A              (en) | 1992-04-20 | 1999-01-12 | Board Of Regents, The University Of Texas System | Gels for encapsulation of biological materials | 
| US6217908B1              (en) | 1992-04-24 | 2001-04-17 | Brown University Research Foundation | Bioadhesive microspheres and their use as drug delivery and imaging systems | 
| US5429602A              (en) | 1992-04-29 | 1995-07-04 | Hauser; Jean-Luc | Programmable portable infusion pump system | 
| WO1993023083A1              (en) | 1992-05-11 | 1993-11-25 | Agouron Pharmaceuticals, Inc. | Anhydrous formulations for administering lipophilic agents | 
| US5250026A              (en) | 1992-05-27 | 1993-10-05 | Destron/Idi, Inc. | Adjustable precision transponder injector | 
| US5556642A              (en) | 1992-07-16 | 1996-09-17 | Tanabe Seiyaku Co., Ltd. | Method for producing sustained release microsphere preparation | 
| US5413672A              (en) | 1992-07-22 | 1995-05-09 | Ngk Insulators, Ltd. | Method of etching sendust and method of pattern-etching sendust and chromium films | 
| US5512293A              (en) | 1992-07-23 | 1996-04-30 | Alza Corporation | Oral sustained release drug delivery device | 
| US5276926A              (en)* | 1992-08-04 | 1994-01-11 | Raquel Lopez | Baby bath and seat | 
| US5279555A              (en) | 1992-08-24 | 1994-01-18 | Merck & Co., Inc. | Device for injecting implants | 
| US5609885A              (en) | 1992-09-15 | 1997-03-11 | Alza Corporation | Osmotic membrane and delivery device | 
| US5827297A              (en) | 1992-10-01 | 1998-10-27 | Medicamat S.A. | Device for transplanting small diameter hair grafts | 
| WO1994009743A1              (en) | 1992-11-05 | 1994-05-11 | R.P. Scherer Corporation | Vented capsule | 
| EP0596161B1              (en) | 1992-11-06 | 1998-02-04 | Texas Instruments Incorporated | Apparatus for subcutaneous introduction of a needle | 
| EP0596161A1              (en) | 1992-11-06 | 1994-05-11 | Texas Instruments Incorporated | Apparatus for subcutaneous introduction of a needle | 
| WO1994010982A1              (en) | 1992-11-17 | 1994-05-26 | Yoshitomi Pharmaceutical Industries, Ltd. | Sustained-release microsphere containing antipsychotic and process for producing the same | 
| US5656299A              (en) | 1992-11-17 | 1997-08-12 | Yoshitomi Pharmaceutical Industries, Ltd. | Sustained release microsphere preparation containing antipsychotic drug and production process thereof | 
| US5871778A              (en) | 1992-11-17 | 1999-02-16 | Yoshitomi Pharmaceutical Industries, Ltd. | Sustained release microsphere preparation containing antipsychotic drug | 
| USD342855S              (en)* | 1992-11-20 | 1994-01-04 | Butler Ii George D | Combined infant cushion and cover | 
| US5260069A              (en) | 1992-11-27 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Pulsatile particles drug delivery system | 
| US5472708A              (en) | 1992-11-27 | 1995-12-05 | Andrx Pharmaceuticals Inc. | Pulsatile particles drug delivery system | 
| US5635213A              (en) | 1992-11-30 | 1997-06-03 | Neopharma Production Ab | Pharmaceutical formulation | 
| US5654010A              (en) | 1992-12-02 | 1997-08-05 | Alkermes, Inc. | Composition for sustained release of human growth hormone | 
| US5667808A              (en) | 1992-12-02 | 1997-09-16 | Alkermes, Inc. | Composition for sustained release of human growth hormone | 
| US6528093B1              (en) | 1992-12-07 | 2003-03-04 | Takeda Chemical Industries, Ltd. | Sustained-release preparation | 
| US5589167A              (en) | 1993-02-23 | 1996-12-31 | Genentech, Inc. | Excipient stabilization of polypeptides treated with organic solvents | 
| US5368588A              (en) | 1993-02-26 | 1994-11-29 | Bettinger; David S. | Parenteral fluid medication reservoir pump | 
| US5981719A              (en) | 1993-03-09 | 1999-11-09 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use | 
| WO1994021262A1              (en) | 1993-03-17 | 1994-09-29 | Alza Corporation | Device for the transdermal administration of alprazolam | 
| US5514110A              (en) | 1993-03-22 | 1996-05-07 | Teh; Eutiquio L. | Automatic flow control device | 
| JP2006213727A              (en) | 1993-04-07 | 2006-08-17 | Scios Inc | Sustained release of peptide | 
| US6284727B1              (en) | 1993-04-07 | 2001-09-04 | Scios, Inc. | Prolonged delivery of peptides | 
| US5630796A              (en) | 1993-04-08 | 1997-05-20 | Oxford Biosciences Limited | Method of delivering powder transdermally with needless injector | 
| US5843891A              (en) | 1993-04-28 | 1998-12-01 | Sherman; Bernard C. | Pharmaceutical acceptable compositions containing an alcohol and a hydrophobic drug | 
| EP0627231A2              (en) | 1993-05-05 | 1994-12-07 | Alza Corporation | Delivery devices with pulsatile effect | 
| US5424286A              (en) | 1993-05-24 | 1995-06-13 | Eng; John | Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same | 
| US5997902A              (en) | 1993-06-23 | 1999-12-07 | Alza Corporation | Ruminal drug delivery device | 
| EP0631794A1              (en) | 1993-06-23 | 1995-01-04 | Hoechst Aktiengesellschaft | Device for administering implants | 
| US5639477A              (en) | 1993-06-23 | 1997-06-17 | Alza Corporation | Ruminal drug delivery device | 
| US5569289A              (en) | 1993-06-24 | 1996-10-29 | Yoon; Inbae | Safety penetrating instrument with penetrating member and cannula moving during penetration and triggered safety member protusion | 
| WO1995001167A2              (en) | 1993-06-25 | 1995-01-12 | Alza Corporation | Incorporating poly-n-vinyl amide in a transdermal system | 
| US5498255A              (en) | 1993-08-17 | 1996-03-12 | Alza Corporation | Osmotic device for protracted pulsatile delivery of agent | 
| US5385887A              (en) | 1993-09-10 | 1995-01-31 | Genetics Institute, Inc. | Formulations for delivery of osteogenic proteins | 
| US5486365A              (en) | 1993-09-17 | 1996-01-23 | Fuji Chemical Industry Co., Ltd. | Calcium hydrogen phosphate, a method for preparing it, and an excipient utilizing it | 
| WO1995009007A1              (en) | 1993-09-29 | 1995-04-06 | Alza Corporation | Monoglyceride/lactate ester permeation enhancer for oxybutynin | 
| US5686097A              (en) | 1993-09-29 | 1997-11-11 | Alza Corporation | Monoglyceride/lactate ester permeation enhancer for codelivery of steroids | 
| WO1995009006A1              (en) | 1993-09-29 | 1995-04-06 | Alza Corporation | Monoglyceride/lactate ester permeation enhancer | 
| US5558637A              (en) | 1993-10-13 | 1996-09-24 | Leiras Oy | Implant injection device | 
| US6913767B1              (en) | 1993-10-25 | 2005-07-05 | Genentech, Inc. | Compositions for microencapsulation of antigens for use as vaccines | 
| US5650173A              (en) | 1993-11-19 | 1997-07-22 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of biodegradable microparticles containing a biologically active agent | 
| US5654008A              (en) | 1993-11-19 | 1997-08-05 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of biodegradable microparticles containing a biologically active agent | 
| US5688801A              (en) | 1993-11-19 | 1997-11-18 | Janssen Pharmaceutica | Method of inhibiting neurotransmitter activity using microencapsulated 3-piperidiny2-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles | 
| US5965168A              (en) | 1993-11-19 | 1999-10-12 | Alkermes Controlled Therapeutics, Inc. Ii | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles | 
| WO1995013799A1              (en) | 1993-11-19 | 1995-05-26 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of biodegradable microparticles containing a biologically active agent | 
| US5770231A              (en) | 1993-11-19 | 1998-06-23 | Alkermes Controlled Therapeutics, Inc. Ii | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles 1,2-benzisothiazoles | 
| US5348544A              (en) | 1993-11-24 | 1994-09-20 | Becton, Dickinson And Company | Single-handedly actuatable safety shield for needles | 
| JPH07196479A              (en) | 1994-01-04 | 1995-08-01 | Unitika Ltd | Method for producing microcapsule | 
| USD358644S              (en) | 1994-01-18 | 1995-05-23 | Bio Medic Data Systems, Inc. | Transponder implanter | 
| US5540665A              (en) | 1994-01-31 | 1996-07-30 | Alza Corporation | Gas driven dispensing device and gas generating engine therefor | 
| US6022561A              (en) | 1994-02-04 | 2000-02-08 | Scotia Lipidteknik Ab | Bilayers preparations | 
| US5713847A              (en) | 1994-02-09 | 1998-02-03 | The University Of Iowa Research Foundation | Human drug delivery device for tinnitus | 
| US5810769A              (en) | 1994-02-25 | 1998-09-22 | Suddeutsche Feinmechanik Gmbh | Cannula for the subcutaneous deposition of an object | 
| JPH09509346A              (en) | 1994-02-25 | 1997-09-22 | ズードドイッチェ・フアインメハニーク・ゲーエムベーハー | Cannula for subcutaneous fixation of target | 
| US5458888A              (en) | 1994-03-02 | 1995-10-17 | Andrx Pharmaceuticals, Inc. | Controlled release tablet formulation | 
| US6007805A              (en) | 1994-03-07 | 1999-12-28 | Imperial College Of Science And Technology | Use of interferon subtype alpha-8 (IFN-α8) to treat viral infections of the liver | 
| US5484403A              (en) | 1994-04-05 | 1996-01-16 | Avid Marketing, Inc. | Hypodermic syringe for implanting solid objects | 
| US5660861A              (en) | 1994-04-28 | 1997-08-26 | Alza Corporation | Effective therapy for epilepsies | 
| WO1995034285A1              (en) | 1994-06-13 | 1995-12-21 | Alza Corporation | Dosage form for administering drug in liquid formulation | 
| WO1996001134A1              (en) | 1994-07-01 | 1996-01-18 | Alza Corporation | Osmotic system for delivering of fluid-sensitive somatotropin to bovine animals | 
| EP0767689B1              (en) | 1994-07-01 | 1999-06-02 | Alza Corporation | Osmotic system for delivering of fluid-sensitive somatotropin to bovine animals | 
| US5557318A              (en) | 1994-07-12 | 1996-09-17 | Koninklijke Ptt Nederland N.V. | Method and apparatus for permitting a viewer to scan through a plurality of video signals provided by a transmitter | 
| US5668170A              (en) | 1994-07-13 | 1997-09-16 | Alza Corporation | Composition and method enhancing transdermal electrotransport agent delivery | 
| WO1996003116A1              (en) | 1994-07-25 | 1996-02-08 | Alkermes Controlled Therapeutics, Inc. | Controlled release of metal cation-stabilized interferon | 
| US5633011A              (en) | 1994-08-04 | 1997-05-27 | Alza Corporation | Progesterone replacement therapy | 
| US5620705A              (en) | 1994-08-04 | 1997-04-15 | Alza Corporation | Progestin tablet | 
| US5574008A              (en) | 1994-08-30 | 1996-11-12 | Eli Lilly And Company | Biologically active fragments of glucagon-like insulinotropic peptide | 
| US5695463A              (en) | 1994-09-27 | 1997-12-09 | Societe De Conseils De Recherches Et D'applications | Safety injection device | 
| US5512549A              (en) | 1994-10-18 | 1996-04-30 | Eli Lilly And Company | Glucagon-like insulinotropic peptide analogs, compositions, and methods of use | 
| US5595759A              (en) | 1994-11-10 | 1997-01-21 | Alza Corporation | Process for providing therapeutic composition | 
| US5836935A              (en) | 1994-11-10 | 1998-11-17 | Ashton; Paul | Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body | 
| US5613954A              (en) | 1994-11-21 | 1997-03-25 | Stryker Corporation | Laparoscopic surgical Y-tube cannula | 
| EP0729747B1              (en) | 1995-03-03 | 1997-05-07 | L'oreal | Use of amphiphilic compounds as thickening agent of non aqueous media and composition obtained | 
| US5464929A              (en) | 1995-03-06 | 1995-11-07 | Ethicon, Inc. | Absorbable polyoxaesters | 
| US6224894B1              (en) | 1995-03-06 | 2001-05-01 | Ethicon, Inc. | Copolymers of absorbable polyoxaesters | 
| US5648088A              (en) | 1995-03-06 | 1997-07-15 | Ethicon, Inc. | Blends of absorbable polyoxaesters containing amines and/or amide groups | 
| US6372256B2              (en) | 1995-03-06 | 2002-04-16 | Ethicon, Inc. | Hydrogels containing absorbable polyoxaamides | 
| US5620698A              (en) | 1995-03-06 | 1997-04-15 | Ethicon, Inc. | Blends of absorbable polyoxaesters containing amines and/or amido groups | 
| US5645850A              (en) | 1995-03-06 | 1997-07-08 | Ethicon, Inc. | Blending containing absorbable polyoxaamides | 
| US5618552A              (en) | 1995-03-06 | 1997-04-08 | Ethicon, Inc. | Absorbable polyoxaesters | 
| US20010026793A1              (en) | 1995-03-06 | 2001-10-04 | Jamiolkowski Dennis D. | Hydrogels containing absorbable polyoxaamides | 
| US6458385B2              (en) | 1995-03-06 | 2002-10-01 | Ethicon, Inc. | Hydrogels containing absorbable polyoxaamides | 
| US20010021377A1              (en) | 1995-03-06 | 2001-09-13 | Jamiolkowski Dennis D. | Hydrogels containing absorbable polyoxaamides | 
| US5607687A              (en) | 1995-03-06 | 1997-03-04 | Ethicon, Inc. | Polymer blends containing absorbable polyoxaesters | 
| US6100346A              (en) | 1995-03-06 | 2000-08-08 | Ethicon, Inc. | Copolymers of polyoxaamides | 
| US5597579A              (en) | 1995-03-06 | 1997-01-28 | Ethicon, Inc. | Blends of absorbable polyoxaamides | 
| US20010012511A1              (en) | 1995-03-06 | 2001-08-09 | Bezwada Rao S. | Method of preventing adhesions with absorbable polyoxaesters | 
| US5595751A              (en) | 1995-03-06 | 1997-01-21 | Ethicon, Inc. | Absorbable polyoxaesters containing amines and/or amido groups | 
| US5962023A              (en) | 1995-03-06 | 1999-10-05 | Ethicon, Inc. | Hydrogels containing absorbable polyoxaamides | 
| US6251435B1              (en) | 1995-03-06 | 2001-06-26 | Ethicon, Inc. | Hydrogels containing absorbable polyoxaamides | 
| US6403655B1              (en) | 1995-03-06 | 2002-06-11 | Ethicon, Inc. | Method of preventing adhesions with absorbable polyoxaesters | 
| US5844017A              (en) | 1995-03-06 | 1998-12-01 | Ethicon, Inc. | Prepolymers of absorbable polyoxaesters containing amines and/or amido groups | 
| US5700583A              (en) | 1995-03-06 | 1997-12-23 | Ethicon, Inc. | Hydrogels of absorbable polyoxaesters containing amines or amido groups | 
| US5698213A              (en) | 1995-03-06 | 1997-12-16 | Ethicon, Inc. | Hydrogels of absorbable polyoxaesters | 
| US5859150A              (en) | 1995-03-06 | 1999-01-12 | Ethicon, Inc. | Prepolymers of absorbable polyoxaesters | 
| US6147168A              (en) | 1995-03-06 | 2000-11-14 | Ethicon, Inc. | Copolymers of absorbable polyoxaesters | 
| US5906816A              (en) | 1995-03-16 | 1999-05-25 | University Of Florida | Method for treatment of autoimmune diseases | 
| US5697914A              (en) | 1995-03-16 | 1997-12-16 | Becton Dickinson And Company | Control forward/flashback forward one hand introducer needle and catheter assembly | 
| US6060450A              (en) | 1995-03-16 | 2000-05-09 | University Of Florida | Method for treatment of autoimmune diseases | 
| US5697113A              (en)* | 1995-03-23 | 1997-12-16 | Aminach Bedding & Furniture Manufacturing Ltd. | Ventilated infant's mattress | 
| US5542682A              (en) | 1995-03-27 | 1996-08-06 | American Variseal | Slant coil spring and seal | 
| US5736159A              (en) | 1995-04-28 | 1998-04-07 | Andrx Pharmaceuticals, Inc. | Controlled release formulation for water insoluble drugs in which a passageway is formed in situ | 
| US5972373A              (en) | 1995-05-02 | 1999-10-26 | Taisho Pharmaceutical Co., Ltd. | Taste masking pharmaceutical composition for oral administration | 
| US5939286A              (en) | 1995-05-10 | 1999-08-17 | University Of Florida | Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them | 
| WO1996036317A1              (en) | 1995-05-18 | 1996-11-21 | Alkermes Controlled Therapeutics, Inc. | Production scale method of forming microparticles | 
| US5922253A              (en) | 1995-05-18 | 1999-07-13 | Alkermes Controlled Therapeutics, Inc. | Production scale method of forming microparticles | 
| US5882676A              (en) | 1995-05-26 | 1999-03-16 | Alza Corporation | Skin permeation enhancer compositions using acyl lactylates | 
| US5718922A              (en) | 1995-05-31 | 1998-02-17 | Schepens Eye Research Institute, Inc. | Intravitreal microsphere drug delivery and method of preparation | 
| WO1996039142A1              (en) | 1995-06-06 | 1996-12-12 | F. Hoffmann-La Roche Ag | Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride | 
| WO1996040139A1              (en) | 1995-06-07 | 1996-12-19 | Alza Corporation | Novel formulations for transdermal delivery of pergolide | 
| WO1996040049A1              (en) | 1995-06-07 | 1996-12-19 | Alza Corporation | Peptide/protein suspended formulations | 
| US5876746A              (en) | 1995-06-07 | 1999-03-02 | Cygnus, Inc. | Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen | 
| US6129761A              (en) | 1995-06-07 | 2000-10-10 | Reprogenesis, Inc. | Injectable hydrogel compositions | 
| US20040101557A1              (en) | 1995-06-07 | 2004-05-27 | Gibson John W. | High viscosity liquid controlled delivery system and medical or surgical device | 
| US7833543B2              (en) | 1995-06-07 | 2010-11-16 | Durect Corporation | High viscosity liquid controlled delivery system and medical or surgical device | 
| US5871770A              (en) | 1995-06-07 | 1999-02-16 | Alza Corporation | Implantable system for delivery of fluid-sensitive agents to animals | 
| US5690952A              (en) | 1995-06-07 | 1997-11-25 | Judy A. Magruder et al. | Implantable system for delivery of fluid-sensitive agents to animals | 
| US5904935A              (en) | 1995-06-07 | 1999-05-18 | Alza Corporation | Peptide/protein suspending formulations | 
| US5725497A              (en) | 1995-06-07 | 1998-03-10 | American Cyanamid Company | Injection dart system | 
| WO1996040355A1              (en) | 1995-06-07 | 1996-12-19 | Cygnus, Inc. | Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen | 
| US5747058A              (en) | 1995-06-07 | 1998-05-05 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system | 
| US5972370A              (en) | 1995-06-07 | 1999-10-26 | Alza Corporation | Peptide/protein suspending formulations | 
| US6607529B1              (en) | 1995-06-19 | 2003-08-19 | Medtronic Vidamed, Inc. | Electrosurgical device | 
| US5782396A              (en) | 1995-08-28 | 1998-07-21 | United States Surgical Corporation | Surgical stapler | 
| US5906830A              (en) | 1995-09-08 | 1999-05-25 | Cygnus, Inc. | Supersaturated transdermal drug delivery systems, and methods for manufacturing the same | 
| US5942253A              (en) | 1995-10-12 | 1999-08-24 | Immunex Corporation | Prolonged release of GM-CSF | 
| US5814323A              (en) | 1995-10-16 | 1998-09-29 | Lever Brothers Company, Division Of Conopco, Inc. | Cosmetic composition | 
| US6120787A              (en) | 1995-10-19 | 2000-09-19 | Biogram Ab | Sustained release particles | 
| WO1997015296A1              (en) | 1995-10-23 | 1997-05-01 | Theratech, Inc. | Buccal delivery of glucagon-like insulinotropic peptides | 
| WO1997015289A1              (en) | 1995-10-25 | 1997-05-01 | Cortecs (Uk) Limited | Solubilisation methods | 
| EP0771817A2              (en) | 1995-10-30 | 1997-05-07 | Laboratorios S.A.L.V.A.T., S.A. | Fatty-acid monoesters of estrogens for the treatment of obesity and/or overweight | 
| US6461605B1              (en) | 1995-11-02 | 2002-10-08 | Schering Corporation | Continuous low-dose cytokine infusion therapy | 
| US5908621A              (en) | 1995-11-02 | 1999-06-01 | Schering Corporation | Polyethylene glycol modified interferon therapy | 
| US5906599A              (en) | 1995-11-09 | 1999-05-25 | Intermed, Inc. | Device for delivering biological agents | 
| US5851451A              (en) | 1995-12-15 | 1998-12-22 | Takeda Chemical Industries, Ltd. | Production of microspheres | 
| US6190700B1              (en) | 1995-12-15 | 2001-02-20 | Takeda Chemical Industries, Ltd. | Production of sustained-release preparation for injection | 
| US6592508B1              (en) | 1995-12-18 | 2003-07-15 | Integrated Implant Systems, Llc | Fiberoptic-guided interstitial seed manual applicator and seed cartridge | 
| US6133249A              (en) | 1995-12-19 | 2000-10-17 | Macnaught Medical Pty Limited | Phospholipid and propylene glycol based lubricant | 
| US5980945A              (en) | 1996-01-16 | 1999-11-09 | Societe De Conseils De Recherches Et D'applications Scientifique S.A. | Sustained release drug formulations | 
| US5672549A              (en) | 1996-01-31 | 1997-09-30 | Sumitomo Bakelite Company Limited | Method of producing epoxy resin-encapsulated semiconductor device | 
| US6261584B1              (en) | 1996-02-02 | 2001-07-17 | Alza Corporation | Sustained delivery of an active agent using an implantable system | 
| US6395292B2              (en) | 1996-02-02 | 2002-05-28 | Alza Corporation | Sustained delivery of an active agent using an implantable system | 
| WO1997028181A2              (en) | 1996-02-02 | 1997-08-07 | Rhomed Incorporated | Post-labeling stabilization of radiolabeled proteins and peptides | 
| US6132420A              (en) | 1996-02-02 | 2000-10-17 | Alza Corporation | Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems | 
| US6156331A              (en) | 1996-02-02 | 2000-12-05 | Alza Corporation | Sustained delivery of an active agent using an implantable system | 
| US6635268B2              (en) | 1996-02-02 | 2003-10-21 | Alza Corporation | Sustained delivery of an active agent using an implantable system | 
| US7655257B2              (en) | 1996-02-02 | 2010-02-02 | Intarcia Therapeutics, Inc. | Sustained delivery of an active agent using an implantable system | 
| US20040039376A1              (en) | 1996-02-02 | 2004-02-26 | Peery John R. | Sustained delivery of an active agent using an implantable system | 
| US5985305A              (en) | 1996-02-02 | 1999-11-16 | Alza Corporation | Sustained delivery of an active agent using an implantable system | 
| US5728396A              (en) | 1996-02-02 | 1998-03-17 | Alza Corporation | Sustained delivery of leuprolide using an implantable system | 
| US6245349B1              (en) | 1996-02-23 | 2001-06-12 | éLAN CORPORATION PLC | Drug delivery compositions suitable for intravenous injection | 
| WO1997031943A1              (en) | 1996-03-01 | 1997-09-04 | Novo Nordisk A/S | Use of a pharmaceutical composition comprising an appetite-suppressing peptide | 
| JPH09241153A              (en) | 1996-03-04 | 1997-09-16 | Q P Corp | Fat emulsion for intravenous injection | 
| US6124281A              (en) | 1996-03-08 | 2000-09-26 | Zeneca Limited | Azolobenzazepine derivatives as neurologically active agents | 
| US6069133A              (en) | 1996-03-14 | 2000-05-30 | The Immune Response Corporation | Targeted delivery of genes encoding interferon | 
| US5703200A              (en) | 1996-03-15 | 1997-12-30 | Ethicon, Inc. | Absorbable copolymers and blends of 6,6-dialkyl-1,4-dioxepan-2-one and its cyclic dimer | 
| US6190702B1              (en) | 1996-03-28 | 2001-02-20 | Takeda Chemical Industries, Ltd. | Sustained-released material prepared by dispersing a lyophilized polypeptide in an oil phase | 
| US5660858A              (en) | 1996-04-03 | 1997-08-26 | Research Triangle Pharmaceuticals | Cyclosporin emulsions | 
| US6204022B1              (en) | 1996-04-12 | 2001-03-20 | Pepgen Corporation And University Of Florida | Low-toxicity human interferon-alpha analogs | 
| US6074673A              (en) | 1996-04-22 | 2000-06-13 | Guillen; Manuel | Slow-release, self-absorbing, drug delivery system | 
| US5807876A              (en) | 1996-04-23 | 1998-09-15 | Vertex Pharmaceuticals Incorporated | Inhibitors of IMPDH enzyme | 
| US5976109A              (en) | 1996-04-30 | 1999-11-02 | Medtronic, Inc. | Apparatus for drug infusion implanted within a living body | 
| US5916598A              (en) | 1996-05-07 | 1999-06-29 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of biodegradable, biocompatible microparticles containing a biologically active agent | 
| WO1997041837A3              (en) | 1996-05-07 | 1998-02-26 | Alkermes Inc | Microparticles | 
| US6110503A              (en) | 1996-05-07 | 2000-08-29 | Alkermes Controlled Therapeutics Inc. | Preparation of biodegradable, biocompatible microparticles containing a biologically active agent | 
| WO1997041837A2              (en) | 1996-05-07 | 1997-11-13 | Alkermes Controlled Therapeutics Inc. Ii | Microparticles | 
| US5792477A              (en) | 1996-05-07 | 1998-08-11 | Alkermes Controlled Therapeutics, Inc. Ii | Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent | 
| WO1997044039A1              (en) | 1996-05-20 | 1997-11-27 | Janssen Pharmaceutica N.V. | Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters | 
| WO1997046204A2              (en) | 1996-06-05 | 1997-12-11 | Ashmont Holdings Limited | Injectable compositions | 
| US6767887B1              (en) | 1996-06-05 | 2004-07-27 | Roche Diagnostics Gmbh | Exendin analogues, processes for their preparation and medicaments containing them | 
| WO1997047339A1              (en) | 1996-06-14 | 1997-12-18 | Filtertek, S.A. | Gravity infusion set for medical infusions | 
| US6258377B1              (en) | 1996-07-02 | 2001-07-10 | Provalis Uk Limited | Hydrophobic preparations containing medium chain monoglycerides | 
| US5932547A              (en) | 1996-07-03 | 1999-08-03 | Alza Corporation | Non-aqueous polar aprotic peptide formulations | 
| WO1998000158A1              (en) | 1996-07-03 | 1998-01-08 | Alza Corporation | Non-aqueous polar aprotic peptide formulations | 
| US6124261A              (en) | 1996-07-03 | 2000-09-26 | Alza Corporation | Non-aqueous polar aprotic peptide formulations | 
| WO1998000157A1              (en) | 1996-07-03 | 1998-01-08 | Alza Corporation | Aqueous formulations of peptides | 
| US6235712B1              (en) | 1996-07-03 | 2001-05-22 | Alza Corporation | Non-aqueous polar aprotic peptide formulations | 
| WO1998000152A1              (en) | 1996-07-03 | 1998-01-08 | Alza Corporation | Non-aqueous protic peptide formulations | 
| WO1998002169A2              (en) | 1996-07-15 | 1998-01-22 | Alza Corporation | Novel formulations for the administration of fluoxetine | 
| US6218431B1              (en) | 1996-07-31 | 2001-04-17 | Bayer Corporation | Substituted biphenyls | 
| US6858576B1              (en) | 1996-08-08 | 2005-02-22 | Amylin Pharmaceuticals, Inc. | Methods for regulating gastrointestinal motility | 
| US8288338B2              (en) | 1996-08-08 | 2012-10-16 | Amylin Pharmaceuticals, Llc | Exendin and exendin agonists for eating disorders | 
| US7521423B2              (en) | 1996-08-08 | 2009-04-21 | Amylin Pharmaceuticals, Inc. | Exendin pharmaceutical compositions | 
| US7297761B2              (en) | 1996-08-08 | 2007-11-20 | Amylin Pharmaceuticals, Inc. | Pharmaceutical compositions containing exendins | 
| US20040266692A1              (en) | 1996-08-08 | 2004-12-30 | Young Andrew A. | Exendin pharmaceutical compositions | 
| US7741269B2              (en) | 1996-08-08 | 2010-06-22 | Amylin Pharmaceuticals, Inc. | Exendins and exendin agonists for weight reduction and obesity | 
| WO1998007412A1              (en) | 1996-08-21 | 1998-02-26 | Alkermes Controlled Therapeutics, Inc. | Controlled release microparticles with a hydrophobic material | 
| US6458924B2              (en) | 1996-08-30 | 2002-10-01 | Novo Nordisk A/S | Derivatives of GLP-1 analogs | 
| US6268343B1              (en) | 1996-08-30 | 2001-07-31 | Novo Nordisk A/S | Derivatives of GLP-1 analogs | 
| WO1998013091A1              (en) | 1996-09-27 | 1998-04-02 | American Home Products Corporation | Medical device for the placement of solid materials | 
| WO1998013092A1              (en) | 1996-09-27 | 1998-04-02 | American Home Products Corporation | Tissue penetration guide | 
| US5984890A              (en) | 1996-09-27 | 1999-11-16 | American Home Products Corporation | Medical device for the placement of solid materials | 
| US6074377A              (en) | 1996-10-10 | 2000-06-13 | Sanfilippo, Ii; Dominic Joseph | Method of installing vascular access device | 
| US6730328B2              (en) | 1996-10-16 | 2004-05-04 | Victoria Knepp Maskiewicz | Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity | 
| WO1998016250A1              (en) | 1996-10-16 | 1998-04-23 | Alza Corporation | Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity | 
| WO1998017315A2              (en) | 1996-10-24 | 1998-04-30 | Alza Corporation | Permeation enhancers for transdermal drug delivery compositions, devices, and methods | 
| US5817129A              (en) | 1996-10-31 | 1998-10-06 | Ethicon, Inc. | Process and apparatus for coating surgical sutures | 
| US6187095B1              (en) | 1996-10-31 | 2001-02-13 | Samsel K. Labrecque | Process and apparatus for coating surgical sutures | 
| US6191102B1              (en) | 1996-11-05 | 2001-02-20 | Eli Lilly And Company | Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity | 
| EP0841359A1              (en) | 1996-11-06 | 1998-05-13 | Ethicon, Inc. | Hydrogels of absorbable polyoxaesters | 
| US6592887B2              (en) | 1996-11-11 | 2003-07-15 | Lts Lohmann Therapie-Systeme Ag | Water soluble film for oral administration with instant wettability | 
| US6177096B1              (en) | 1996-11-11 | 2001-01-23 | Lts Lohmann Therapie-Systeme Gmbh | Water soluble film for oral administration with instant wettability | 
| US8865202B2              (en) | 1996-11-11 | 2014-10-21 | Lts Lohmann Therapie-Systeme Ag | Water soluble film for oral administration with instant wettability | 
| US6284264B1              (en) | 1996-11-11 | 2001-09-04 | Lts Lohmann Therapie-Systeme Gmbh | Water soluble film for oral administration with instant wettability | 
| US5948430A              (en) | 1996-11-11 | 1999-09-07 | Lts Lohmann Therapie-Systeme Gmbh | Water soluble film for oral administration with instant wettability | 
| US6709671B2              (en) | 1996-11-11 | 2004-03-23 | Lts Lohmann Therapie-Systeme Ag | Water soluble film for oral administration with instant wettability | 
| US5928666A              (en) | 1996-11-12 | 1999-07-27 | Cygnus Inc. | Crystalline form of estradiol and pharmaceutical formulations comprising same | 
| WO1998020930A1              (en) | 1996-11-15 | 1998-05-22 | Alza Corporation | Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems | 
| US20060013879A9              (en) | 1996-12-20 | 2006-01-19 | Brodbeck Kevin J | Gel composition and methods | 
| US6468961B1              (en) | 1996-12-20 | 2002-10-22 | Alza Corporation | Gel composition and methods | 
| WO1998027963A2              (en) | 1996-12-20 | 1998-07-02 | Alza Corporation | Gel composition and methods | 
| US6673767B1              (en) | 1996-12-20 | 2004-01-06 | Alza Corporation | Gel composition and methods | 
| WO1998027960A2              (en) | 1996-12-20 | 1998-07-02 | Bioglan Ireland (R & D) Limited | A nitroimidazole gel composition | 
| WO1998027962A2              (en) | 1996-12-20 | 1998-07-02 | Alza Corporation | Injectable depot gel composition and method of preparing the composition | 
| US6331311B1              (en) | 1996-12-20 | 2001-12-18 | Alza Corporation | Injectable depot gel composition and method of preparing the composition | 
| US6130200A              (en) | 1996-12-20 | 2000-10-10 | Alza Corporation | Gel composition and methods | 
| US20030044467A1              (en) | 1996-12-20 | 2003-03-06 | Brodbeck Kevin J. | Gel composition and methods | 
| US20020034532A1              (en) | 1996-12-20 | 2002-03-21 | Brodbeck Kevin J. | Injectable depot gel composition and method of preparing the composition | 
| US7115569B2              (en) | 1997-01-07 | 2006-10-03 | Amylin Pharmaceuticals, Inc. | Exendins, exendin agonists, and methods for their use | 
| US6989366B2              (en) | 1997-01-07 | 2006-01-24 | Amylin Pharmaceuticals, Inc. | Exendins, exendin agonists, and methods for their use | 
| US20020137666A1              (en) | 1997-01-07 | 2002-09-26 | Nigel Robert Arnold Beeley | Use of exendins and agonists thereof for the reduction of food intake | 
| US6956026B2              (en) | 1997-01-07 | 2005-10-18 | Amylin Pharmaceuticals, Inc. | Use of exendins for the reduction of food intake | 
| US7138375B2              (en) | 1997-01-07 | 2006-11-21 | Amylin Pharmaceuticals, Inc. | Use of exendins and agonists thereof for lowering plasma lipid | 
| WO1998030231A1              (en) | 1997-01-07 | 1998-07-16 | Amylin Pharmaceuticals, Inc. | Use of exendins and agonists thereof for the reduction of food intake | 
| WO1998032463A2              (en) | 1997-01-28 | 1998-07-30 | Pharmacia & Upjohn Company | Lyophilizate of lipid complex of water insoluble porphyrins | 
| US5945126A              (en) | 1997-02-13 | 1999-08-31 | Oakwood Laboratories L.L.C. | Continuous microsphere process | 
| US6217906B1              (en) | 1997-03-24 | 2001-04-17 | Alza Corporation | Self adjustable exit port | 
| WO1998042317A2              (en) | 1997-03-24 | 1998-10-01 | Alza Corporation | Implantable delivery device with self adjustable exit port | 
| US5997527A              (en) | 1997-03-24 | 1999-12-07 | Alza Corporation | Self adjustable exit port | 
| US5874388A              (en) | 1997-04-02 | 1999-02-23 | Dow Corning Corporation | Lubricant composition for disc brake caliper pin and a disc brake asembly containing the lubricant | 
| US6127520A              (en) | 1997-04-15 | 2000-10-03 | Regents Of The University Of Michigan | Compositions and methods for the inhibition of neurotransmitter uptake of synaptic vesicles | 
| WO1998047487A1              (en) | 1997-04-17 | 1998-10-29 | Dumex-Alpharma A/S | A novel bioadhesive drug delivery system based on liquid crystals | 
| US6217893B1              (en) | 1997-04-18 | 2001-04-17 | Pharma Biotech | Sustained-release compositions and method for preparing same | 
| US20040265273A1              (en) | 1997-04-28 | 2004-12-30 | Hong Li | Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors | 
| WO1998051282A1              (en) | 1997-05-13 | 1998-11-19 | Imarx Pharmaceutical Corp. | Solid porous matrices and methods of making and using the same | 
| US6113947A              (en) | 1997-06-13 | 2000-09-05 | Genentech, Inc. | Controlled release microencapsulated NGF formulation | 
| US20020004481A1              (en) | 1997-06-13 | 2002-01-10 | Jeffrey L. Cleland | Controlled release microencapsulated ngf formulation | 
| WO1998058698A1              (en) | 1997-06-20 | 1998-12-30 | Akzo Nobel N.V. | Preloaded implantation device | 
| WO1999003453A1              (en) | 1997-07-14 | 1999-01-28 | Lek, Tovarna Farmacevtskih In Kemic^¿Nih Izdelkov , D.D. | Novel pharmaceutical formulation with controlled release of active substances | 
| WO1999004768A2              (en) | 1997-07-25 | 1999-02-04 | Alza Corporation | Osmotic delivery system flow modulator apparatus | 
| US6287295B1              (en) | 1997-07-25 | 2001-09-11 | Alza Corporation | Osmotic delivery system, osmotic delivery system semimpermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems | 
| WO1999004767A2              (en) | 1997-07-25 | 1999-02-04 | Alza Corporation | Osmotic delivery system with semipermeable plug | 
| US6840931B2              (en) | 1997-07-25 | 2005-01-11 | Alza Corporation | Osmotic delivery system flow modulator apparatus and method | 
| US20010027311A1              (en) | 1997-07-25 | 2001-10-04 | Guohua Chen | Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems | 
| US20030114837A1              (en) | 1997-07-25 | 2003-06-19 | Peterson Lewis L. | Osmotic delivery system flow modulator apparatus and method | 
| US6923800B2              (en) | 1997-07-25 | 2005-08-02 | Alza Corporation | Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems | 
| US20050131389A1              (en) | 1997-07-25 | 2005-06-16 | Peterson Lewis L. | Osmotic delivery system flow modulator apparatus and method | 
| US6524305B1              (en) | 1997-07-25 | 2003-02-25 | Alza Corporation | Osmotic delivery system flow modulator apparatus and method | 
| US7157555B1              (en) | 1997-08-08 | 2007-01-02 | Amylin Pharmaceuticals, Inc. | Exendin agonist compounds | 
| US6478768B1              (en) | 1997-08-08 | 2002-11-12 | Gaplast Gmbh | Implant syringe | 
| WO1999012549A2              (en) | 1997-09-09 | 1999-03-18 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Controlled release microsphere delivery system | 
| US6023802A              (en)* | 1997-09-10 | 2000-02-15 | King; Susan Melton | Infant sleeper | 
| US6172046B1              (en) | 1997-09-21 | 2001-01-09 | Schering Corporation | Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection | 
| US5989463A              (en) | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices | 
| WO1999016419A1              (en) | 1997-09-29 | 1999-04-08 | Inhale Therapeutic Systems, Inc. | Perforated microparticles and methods of use | 
| JPH11100353A              (en) | 1997-09-29 | 1999-04-13 | Esupo Kk | Refined and deodorized liquid ester wax and its composition | 
| US6133429A              (en) | 1997-10-03 | 2000-10-17 | Becton Dickinson And Company | Chromophores useful for the preparation of novel tandem conjugates | 
| USD399821S              (en)* | 1997-11-07 | 1998-10-20 | Motorola, Inc. | Front section of a battery charger | 
| WO1999025728A1              (en) | 1997-11-14 | 1999-05-27 | Amylin Pharmaceuticals, Inc. | Novel exendin agonist compounds | 
| US6569420B2              (en) | 1997-12-08 | 2003-05-27 | Genentech, Inc. | Human interferon-ε: a type I interferon | 
| WO1999029306A1              (en) | 1997-12-12 | 1999-06-17 | Biohybrid Technologies, Inc. | Devices for cloaking transplanted cells | 
| US20030059471A1              (en) | 1997-12-15 | 2003-03-27 | Compton Bruce Jon | Oral delivery formulation | 
| US6375978B1              (en) | 1997-12-22 | 2002-04-23 | Alza Corporation | Rate controlling membranes for controlled drug delivery devices | 
| US6976981B2              (en) | 1997-12-29 | 2005-12-20 | Alza Corporation | Osmotic delivery system with membrane plug retention mechanism | 
| US6270787B1              (en) | 1997-12-29 | 2001-08-07 | Alza Corporation | Osmotic delivery system with membrane plug retention mechanism | 
| US6190350B1              (en) | 1997-12-29 | 2001-02-20 | Alza Corporation | Implanter device for subcutaneous implants | 
| EP1300129A3              (en) | 1997-12-29 | 2003-05-14 | Alza Corporation | Implant vial | 
| WO1999033446A1              (en) | 1997-12-29 | 1999-07-08 | Alza Corporation | Osmotic delivery system with membrane plug retention mechanism | 
| US6899887B2              (en) | 1997-12-29 | 2005-05-31 | Micron Technology, Inc. | Osmotic delivery system with membrane plug retention mechanism | 
| EP1300129A2              (en) | 1997-12-29 | 2003-04-09 | Alza Corporation | Implant vial | 
| US20010022974A1              (en) | 1997-12-29 | 2001-09-20 | Rupal Ayer | Osmotic delivery system with membrane plug retention mechanism | 
| EP1300173A2              (en) | 1997-12-29 | 2003-04-09 | Alza Corporation | Implanter device for subcutaneous implants | 
| US20040243106A1              (en) | 1997-12-29 | 2004-12-02 | Rupal Ayer | Osmotic delivery device with membrane plug retention mechanism | 
| US20010021822A1              (en) | 1997-12-29 | 2001-09-13 | Rupal Ayer | Osmotic delivery system with membrane plug retention mechanism | 
| US6113938A              (en) | 1997-12-30 | 2000-09-05 | Alza Corporation | Beneficial agent delivery system with membrane plug and method for controlling delivery of beneficial agents | 
| WO1999033449A1              (en) | 1997-12-30 | 1999-07-08 | Alza Corporation | Beneficial agent delivery system with membrane plug | 
| US20040024068A1              (en) | 1998-01-23 | 2004-02-05 | Trustees Of Tufts College | Antimicrobial compounds | 
| WO1999039700A1              (en) | 1998-02-06 | 1999-08-12 | Eurand International S.P.A. | Pharmaceutical compositions in form of nanoparticles comprising lipidic substances and amphiphilic substances and related preparation process | 
| US6017545A              (en) | 1998-02-10 | 2000-01-25 | Modi; Pankaj | Mixed micellar delivery system and method of preparation | 
| WO1999040788A1              (en) | 1998-02-13 | 1999-08-19 | Amylin Pharmaceuticals, Inc. | Inotropic and diuretic effects of exendin and glp-1 | 
| US6703359B1              (en) | 1998-02-13 | 2004-03-09 | Amylin Pharmaceuticals, Inc. | Inotropic and diuretic effects of exendin and GLP-1 | 
| US7928065B2              (en) | 1998-02-13 | 2011-04-19 | Amylin Pharmaceuticals, Inc. | Methods of treatment using exendin peptides or GLP-1 peptides | 
| US6402716B1              (en) | 1998-02-20 | 2002-06-11 | Lg Chemical Ltd. | Syringe assembly | 
| USD408917S              (en) | 1998-02-26 | 1999-04-27 | Minnesota Mining And Manufacturing Company | Membrane support structure of a flow through cell for blood gas measurement | 
| WO1999044659A1              (en) | 1998-03-02 | 1999-09-10 | Medrad, Inc. | Syringes and plungers for use therein | 
| US6245357B1              (en) | 1998-03-06 | 2001-06-12 | Alza Corporation | Extended release dosage form | 
| US6183461B1              (en) | 1998-03-11 | 2001-02-06 | Situs Corporation | Method for delivering a medication | 
| US20020136848A1              (en) | 1998-03-12 | 2002-09-26 | Fumio Yoshii | Lactone-containing resin composition, molded object thereof, and film | 
| US6029361A              (en) | 1998-03-25 | 2000-02-29 | Ultratech Stepper, Inc. | Air-guage nozzle probe structure for microlithographic image focusing | 
| US6395282B1              (en) | 1998-04-16 | 2002-05-28 | University Of Rochester | Immunogenic conjugates of Gram-negative bacterial autoinducer molecules | 
| US6074660A              (en) | 1998-04-20 | 2000-06-13 | Ethicon, Inc. | Absorbable polyoxaesters containing amines and/ or amido groups | 
| WO1999062501A1              (en) | 1998-05-29 | 1999-12-09 | Sumitomo Pharmaceuticals Company, Limited | Controlled release preparations having multi-layer structure | 
| EP1084703A1              (en) | 1998-05-29 | 2001-03-21 | Sumitomo Pharmaceuticals Company, Limited | Controlled release preparations having multi-layer structure | 
| US7101567B1              (en) | 1998-05-29 | 2006-09-05 | Dainippon Sumitomo Pharma Co., Ltd. | Controlled release preparations having multi-layer structure | 
| WO1999064061A1              (en) | 1998-06-12 | 1999-12-16 | Bionebraska, Inc. | GLUCAGON-LIKE PEPTIDE-1 IMPROVES β-CELL RESPONSE TO GLUCOSE IN SUBJECTS WITH IMPAIRED GLUCOSE TOLERANCE | 
| US6277413B1              (en) | 1998-07-17 | 2001-08-21 | Skyepharma, Inc. | Biodegradable compositions for the controlled release of encapsulated substances | 
| US6472512B1              (en) | 1998-07-21 | 2002-10-29 | Human Genome Sciences, Inc. | Keratinocyte derived interferon | 
| US20040225113A1              (en) | 1998-07-21 | 2004-11-11 | Lafleur David W. | Keratinocyte derived interferon | 
| US6270700B1              (en) | 1998-07-23 | 2001-08-07 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Encapsulation of water soluble peptides | 
| USD415073S              (en)* | 1998-08-17 | 1999-10-12 | ScooterBug, Inc. | Stroller | 
| US6720407B1              (en) | 1998-08-28 | 2004-04-13 | Eli Lilly And Company | Method for administering insulinotropic peptides | 
| US6551613B1              (en) | 1998-09-08 | 2003-04-22 | Alza Corporation | Dosage form comprising therapeutic formulation | 
| WO2000013663A1              (en) | 1998-09-09 | 2000-03-16 | Alza Corporation | Dosage form comprising liquid formulation | 
| US5951521A              (en) | 1998-09-25 | 1999-09-14 | Minimed Inc. | Subcutaneous implantable sensor set having the capability to remove deliver fluids to an insertion site | 
| US6248112B1              (en) | 1998-09-30 | 2001-06-19 | C. R. Bard, Inc. | Implant delivery system | 
| US20040047888A1              (en) | 1998-09-30 | 2004-03-11 | Kenison Dale C. | Pellet implant system for immediate and delayed release of antiparasitic drug | 
| US6447522B2              (en) | 1998-09-30 | 2002-09-10 | C. R. Bard, Inc. | Implant delivery system | 
| US6645192B2              (en) | 1998-09-30 | 2003-11-11 | Ivy Animal Health, Inc. | Pellet implant system for immediate and delayed release of antiparasitic drug | 
| US6284725B1              (en) | 1998-10-08 | 2001-09-04 | Bionebraska, Inc. | Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue | 
| US6053927A              (en)* | 1998-10-15 | 2000-04-25 | Rsh-Gs Trust | Apparatus and method for implant removal | 
| US6544239B2              (en) | 1998-10-16 | 2003-04-08 | Bio-Plexus Delaware, Inc. | Releasable locking needle assembly with optional release accessory therefor | 
| US20020048600A1              (en) | 1998-11-02 | 2002-04-25 | Padmanabh Bhatt | Controlled delivery of active agents | 
| WO2000029206A1              (en) | 1998-11-13 | 2000-05-25 | Sensor Technologies Inc. | Monodisperse preparations useful with implanted devices | 
| US20040157951A1              (en) | 1998-11-13 | 2004-08-12 | Wolf David E. | Monodisperse preparations useful with implanted devices | 
| US20030060425A1              (en) | 1998-11-24 | 2003-03-27 | Ahlem Clarence N. | Immune modulation method using steroid compounds | 
| US6903186B1              (en) | 1998-12-07 | 2005-06-07 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S | Analogues of GLP-1 | 
| US6419952B2              (en) | 1998-12-17 | 2002-07-16 | Alza Corporation | Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings | 
| US20010036472A1              (en) | 1998-12-17 | 2001-11-01 | Wong Patrick S.-L. | Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings | 
| WO2000038652A1              (en) | 1998-12-23 | 2000-07-06 | Amgen Inc. | Polyol/oil suspensions for the sustained release of proteins | 
| US6997922B2              (en) | 1998-12-31 | 2006-02-14 | Alza Corporation | Osmotic delivery system having space efficient piston | 
| US6544252B1              (en) | 1998-12-31 | 2003-04-08 | Alza Corporation | Osmotic delivery system having space efficient piston | 
| WO2000039280A2              (en) | 1998-12-31 | 2000-07-06 | Viragen, Inc. | Leukocyte-derived interferon preparations | 
| WO2000040273A2              (en) | 1999-01-08 | 2000-07-13 | Vical Incorporated | Treatment of viral diseases using an interferon omega expressing polynucleotide | 
| US6703225B1              (en) | 1999-01-12 | 2004-03-09 | Sumitomo Pharmaceuticals Company, Limited | Interferon-α | 
| US6433144B1              (en) | 1999-01-12 | 2002-08-13 | Viragen, Inc. | Compositions of highly-purified natural mixtures of type I Interferon derived from leukocytes and methods | 
| US20060069029A1              (en) | 1999-01-14 | 2006-03-30 | Kolterman Orville G | Exendin analog formulations | 
| US7153825B2              (en) | 1999-01-14 | 2006-12-26 | Amylin Pharmaceuticals, Inc. | Methods for glucagon suppression using modified exendins | 
| US20090215694A1              (en) | 1999-01-14 | 2009-08-27 | Amylin Pharmaceuticals, Inc | Lyophilized Formulations of Exendins and Exendin Agonist Analogs | 
| WO2000041548A2              (en) | 1999-01-14 | 2000-07-20 | Amylin Pharmaceuticals, Inc. | Methods for glucagon suppression | 
| US6872700B1              (en) | 1999-01-14 | 2005-03-29 | Amylin Pharmaceuticals, Inc. | Methods for glucagon suppression | 
| US6902744B1              (en) | 1999-01-14 | 2005-06-07 | Amylin Pharmaceuticals, Inc. | Exendin agonist formulations and methods of administration thereof | 
| US20150231256A1              (en) | 1999-02-08 | 2015-08-20 | Intarcia Therapeutics Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles | 
| US20080226625A1              (en) | 1999-02-08 | 2008-09-18 | Intarcia Therapeutics, Inc. | Stable non- aqueous single phase viscous vehicles and formulations utlizing such vehicles | 
| US8048438B2              (en) | 1999-02-08 | 2011-11-01 | Intarcia Therapeutics, Inc. | Stable non- aqueous single phase viscous vehicles and formulations utilizing such vehicles | 
| US20030108609A1              (en) | 1999-02-08 | 2003-06-12 | Berry Stephen A. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles | 
| US20110160708A1              (en) | 1999-02-08 | 2011-06-30 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utlizing such vehicles | 
| US20170119855A1              (en) | 1999-02-08 | 2017-05-04 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles | 
| US8268341B2              (en) | 1999-02-08 | 2012-09-18 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles | 
| WO2000045790A2              (en) | 1999-02-08 | 2000-08-10 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles | 
| US20080226689A1              (en) | 1999-02-08 | 2008-09-18 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles | 
| US8992961B2              (en) | 1999-02-08 | 2015-03-31 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles | 
| US8173150B2              (en) | 1999-02-08 | 2012-05-08 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utlizing such vehicles | 
| US7258869B1              (en) | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle | 
| US7919109B2              (en) | 1999-02-08 | 2011-04-05 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles | 
| US8372424B2              (en) | 1999-02-08 | 2013-02-12 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles | 
| US20170319662A1              (en) | 1999-02-08 | 2017-11-09 | Intarcia Therapeutics Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles | 
| US6451974B1              (en) | 1999-03-17 | 2002-09-17 | Novo Nordisk A/S | Method of acylating peptides and novel acylating agents | 
| US6835194B2              (en) | 1999-03-18 | 2004-12-28 | Durect Corporation | Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners | 
| WO2000054745A2              (en) | 1999-03-18 | 2000-09-21 | Durect Corporation | Devices and methods for pain management | 
| US6541021B1              (en) | 1999-03-18 | 2003-04-01 | Durect Corporation | Devices and methods for pain management | 
| WO2000059476A1              (en) | 1999-04-05 | 2000-10-12 | Pharmaceutical Discovery Corporation | Methods for fine powder formation | 
| US6670368B1              (en) | 1999-04-06 | 2003-12-30 | Astrazeneca Ab | Pyrimidine compounds with pharmaceutical activity | 
| EP1046399A1              (en) | 1999-04-19 | 2000-10-25 | Schering Corporation | HCV combination therapy, containing ribavirin in association with antioxidants | 
| US6924264B1              (en) | 1999-04-30 | 2005-08-02 | Amylin Pharmaceuticals, Inc. | Modified exendins and exendin agonists | 
| WO2000066138A2              (en) | 1999-04-30 | 2000-11-09 | Bionebraska, Inc. | Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue | 
| WO2000066087A2              (en) | 1999-05-03 | 2000-11-09 | Southern Biosystems, Inc. | Emulsion-based processes for making microparticles | 
| WO2000067728A2              (en) | 1999-05-07 | 2000-11-16 | Pharmasol Gmbh | Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same | 
| USD430671S              (en) | 1999-05-10 | 2000-09-05 | Shute Wallace B | Obstetrical forceps | 
| US6428517B1              (en) | 1999-05-10 | 2002-08-06 | Milestone Scientific, Inc. | Hand-piece for injection device with a retractable and rotating needle | 
| US6329336B1              (en) | 1999-05-17 | 2001-12-11 | Conjuchem, Inc. | Long lasting insulinotropic peptides | 
| US6849714B1              (en) | 1999-05-17 | 2005-02-01 | Conjuchem, Inc. | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components | 
| US6593295B2              (en) | 1999-05-17 | 2003-07-15 | Conjuchem, Inc. | Long lasting insulinotropic peptides | 
| US6506724B1              (en) | 1999-06-01 | 2003-01-14 | Amylin Pharmaceuticals, Inc. | Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus | 
| US6146139A              (en) | 1999-06-01 | 2000-11-14 | Harrison, Iii; Louis V. | Forceps apparatus | 
| US20060233841A1              (en) | 1999-06-04 | 2006-10-19 | Brodbeck Kevin J | Implantable gel compositions and method of manufacture | 
| US6485706B1              (en) | 1999-06-04 | 2002-11-26 | Delrx Pharmaceutical Corp. | Formulations comprising dehydrated particles of pharma-ceutical agents and process for preparing the same | 
| US20030059376A1              (en) | 1999-06-04 | 2003-03-27 | Libbey Miles A. | Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same | 
| US20010040326A1              (en) | 1999-06-14 | 2001-11-15 | Lord Corporation | Resilient member with deformed element and method of forming same | 
| US6833256B1              (en) | 1999-06-22 | 2004-12-21 | University Of Maryland | Interferon tau mutants and methods for making them | 
| US6528486B1              (en) | 1999-07-12 | 2003-03-04 | Zealand Pharma A/S | Peptide agonists of GLP-1 activity | 
| US6174547B1              (en) | 1999-07-14 | 2001-01-16 | Alza Corporation | Dosage form comprising liquid formulation | 
| US7766924B1              (en) | 1999-07-28 | 2010-08-03 | Cardica, Inc. | System for performing anastomosis | 
| USD445975S1              (en)* | 1999-08-27 | 2001-07-31 | Black & Decker, Inc. | Base unit for a hand held vacuum cleaner | 
| US6887470B1              (en) | 1999-09-10 | 2005-05-03 | Conjuchem, Inc. | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components | 
| WO2001019345A1              (en) | 1999-09-10 | 2001-03-22 | Astrazeneca Ab | Method to obtain microparticles | 
| US6514500B1              (en) | 1999-10-15 | 2003-02-04 | Conjuchem, Inc. | Long lasting synthetic glucagon like peptide {GLP-!} | 
| US6887849B2              (en) | 1999-10-15 | 2005-05-03 | Conjuchem, Inc. | Long lasting synthetic glucagon-like peptide {GLP-1} | 
| US6821949B2              (en) | 1999-10-15 | 2004-11-23 | Conjuchem, Inc. | Long lasting synthetic glucagon-like peptide (GLP-1) | 
| WO2001028631A1              (en) | 1999-10-15 | 2001-04-26 | Deschutes Medical Products, Inc. | Brachytherapy instrument and methods | 
| US6458387B1              (en) | 1999-10-18 | 2002-10-01 | Epic Therapeutics, Inc. | Sustained release microspheres | 
| WO2001028525A2              (en) | 1999-10-21 | 2001-04-26 | Alkermes Controlled Therapeutics, Inc. | Method of producing sub-micron particles of biologically active agents | 
| US6436091B1              (en) | 1999-11-16 | 2002-08-20 | Microsolutions, Inc. | Methods and implantable devices and systems for long term delivery of a pharmaceutical agent | 
| US7022674B2              (en) | 1999-12-16 | 2006-04-04 | Eli Lilly And Company | Polypeptide compositions with improved stability | 
| WO2001043528A2              (en) | 1999-12-17 | 2001-06-21 | Durect Corporation | Devices and methods in intracerebrospinal delivery of morphine-6-glucuronide | 
| US6508808B1              (en) | 1999-12-21 | 2003-01-21 | Alza Corporation | Valve for osmotic devices | 
| US6682522B2              (en) | 1999-12-21 | 2004-01-27 | Alza Corporation | Valve for osmotic devices | 
| US20010031790A1              (en) | 1999-12-22 | 2001-10-18 | Beisswenger Paul J. | Treatment for complications of type 2 diabetes | 
| US6283949B1              (en) | 1999-12-27 | 2001-09-04 | Advanced Cardiovascular Systems, Inc. | Refillable implantable drug delivery pump | 
| WO2001051041A1              (en) | 2000-01-13 | 2001-07-19 | Osmotica Corp. | Osmotic device containing venlafaxine and an anti-psychotic agent | 
| US6572890B2              (en) | 2000-01-13 | 2003-06-03 | Osmotica Corp. | Osmotic device containing venlafaxine and an anti-psychotic agent | 
| US20020012818A1              (en) | 2000-01-19 | 2002-01-31 | Sakari Ruppi | Coated body with nanocrystalline CVD coating for enhanced edge toughness and reduced friction | 
| US20030186858A1              (en) | 2000-01-31 | 2003-10-02 | Arentsen Anne Charlotte | Crystallisation of a GLP-1 analogue | 
| US20030138491A1              (en) | 2000-02-10 | 2003-07-24 | Alkermes Controlled Therapeutics, Inc. | Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins | 
| US20030032947A1              (en) | 2000-02-15 | 2003-02-13 | Microsolutions, Inc. | Osmotic pump drug delivery systems and methods | 
| US6464688B1              (en) | 2000-02-15 | 2002-10-15 | Microsolutions, Inc. | Osmotic pump delivery system with flexible drug compartment | 
| US6471688B1              (en) | 2000-02-15 | 2002-10-29 | Microsolutions, Inc. | Osmotic pump drug delivery systems and methods | 
| US20030040699A1              (en)* | 2000-03-13 | 2003-02-27 | Christine Talling | Device for inserting implants | 
| WO2001068168A1              (en) | 2000-03-13 | 2001-09-20 | Leiras Oy | Device for inserting implants | 
| US6579851B2              (en) | 2000-03-14 | 2003-06-17 | Amylin Pharmaceuticals, Inc. | Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility | 
| US20030211974A1              (en) | 2000-03-21 | 2003-11-13 | Brodbeck Kevin J. | Gel composition and methods | 
| US20010031940A1              (en) | 2000-03-23 | 2001-10-18 | Hans-Joachim Loos | Device for administering implants | 
| US20020098180A1              (en) | 2000-03-24 | 2002-07-25 | Huan-Yao Lei | Fullerene pharmaceutical compositions for preventing or treating disorders | 
| US9044209B2              (en) | 2000-04-14 | 2015-06-02 | Attenuex Technologies, Inc. | Method of removing an inflated implant | 
| US20020001631A1              (en) | 2000-04-19 | 2002-01-03 | Franklin Okumu | Sustained release formulations | 
| US6992065B2              (en) | 2000-04-19 | 2006-01-31 | Genentech, Inc. | Sustained release formulations | 
| WO2001078683A2              (en) | 2000-04-19 | 2001-10-25 | Genentech, Inc. | Sustained release formulations comprising growth hormone | 
| US6875748B2              (en) | 2000-04-21 | 2005-04-05 | Vical Incorporated | Compositions and methods for in vivo delivery of polynucleotide-based therapeutics | 
| US6589157B2              (en) | 2000-05-18 | 2003-07-08 | Integrated Implant Systems, L.L.C. | Drive mechanism for medical instrument | 
| US6706689B2              (en) | 2000-05-19 | 2004-03-16 | Amylin Pharmaceuticals, Inc. | Treatment of acute coronary syndrome with GLP-1 | 
| US20030113380A1              (en) | 2000-05-25 | 2003-06-19 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability | 
| US6667061B2              (en) | 2000-05-25 | 2003-12-23 | Alkermes Controlled Therapeutics, Inc. | Preparation of injectable suspensions having improved injectability | 
| US6495164B1              (en) | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability | 
| US7084243B2              (en) | 2000-06-16 | 2006-08-01 | Eli Lilly And Company | Glucagon-like peptide-1 analogs | 
| US20020037309A1              (en) | 2000-08-10 | 2002-03-28 | Alkermes Controlled Therapeutics, Inc. | Process for the preparation of polymer-based sustained release compositions | 
| US6547250B1              (en) | 2000-08-21 | 2003-04-15 | Westport Research Inc. | Seal assembly with two sealing mechanisms for providing static and dynamic sealing | 
| US20100331868A1              (en) | 2000-08-24 | 2010-12-30 | Bardy Gust H | Method For Constructing An Instrument With A Two-Part Plunger For Subcutaneous Implantation | 
| US8454552B2              (en) | 2000-08-24 | 2013-06-04 | Cardiac Science Corporation | Method for constructing an instrument with a covered bore for subcutaneous implantation | 
| US8251946B2              (en) | 2000-08-24 | 2012-08-28 | Cardiac Science, Inc. | Method for constructing an instrument with a two-part plunger for subcutaneous implantation | 
| US20040115236A1              (en) | 2000-10-06 | 2004-06-17 | Chan Tai Wah | Devices and methods for management of inflammation | 
| WO2002028366A2              (en) | 2000-10-06 | 2002-04-11 | Durect Corporation | Devices and methods for management of inflammation | 
| WO2002036072A2              (en) | 2000-11-03 | 2002-05-10 | Biomedicines, Inc. | Method for short-term and long-term drug dosimetry | 
| US20050201980A1              (en) | 2000-11-03 | 2005-09-15 | Moran Stanford M. | Method for short-term and long-term drug dosimetry | 
| US7727519B2              (en) | 2000-11-03 | 2010-06-01 | Intarcia Therapeutics, Inc. | Method for treating hepatitis C virus with omega interferon | 
| US20020197235A1              (en) | 2000-11-03 | 2002-12-26 | Moran Stanford Mark | Method for short-term and long-term drug dosimetry | 
| WO2002067895A2              (en) | 2000-11-16 | 2002-09-06 | Durect Corporation | Implant dosage form and use thereof for the delivery of a cholesterol lowering agent | 
| US6626863B1              (en) | 2000-11-22 | 2003-09-30 | Nusaf, L.L.C. | Safety syringe | 
| WO2002043800A2              (en) | 2000-11-29 | 2002-06-06 | Durect Corporation | Devices and methods for controlled delivery from a drug delivery device | 
| US20050070883A1              (en) | 2000-11-29 | 2005-03-31 | Brown James E | Devices and methods for controlled delivery from a drug delivery device | 
| WO2002045752A2              (en) | 2000-12-08 | 2002-06-13 | Leo Pharma A/S | Dermal anti-inflammatory composition | 
| US7199217B2              (en) | 2000-12-13 | 2007-04-03 | Eli Lilly And Company | Amidated glucagon-like peptide-1 | 
| WO2002047716A2              (en) | 2000-12-13 | 2002-06-20 | Eli Lilly And Company | Chronic treatment regimen using glucagon-like insulinotropic peptides | 
| US20020141985A1              (en) | 2000-12-14 | 2002-10-03 | Amylin Parmaceuticals, Inc. | Peptide YY and peptide YY agonists for treatment of metabolic disorders | 
| US8273713B2              (en) | 2000-12-14 | 2012-09-25 | Amylin Pharmaceuticals, Llc | Methods of treating obesity using PYY[3-36] | 
| US20020077599A1              (en)* | 2000-12-19 | 2002-06-20 | Animas Corporation | Transcutaneous inserter for low-profile infusion sets | 
| US6899898B2              (en) | 2000-12-21 | 2005-05-31 | Nektar Therapeutics | Induced phase transition method for the production of microparticles containing hydrophobic active agents | 
| USD472896S1              (en)* | 2000-12-23 | 2003-04-08 | Andreas Peiker | Telephone support | 
| USD456776S1              (en)* | 2001-01-23 | 2002-05-07 | Datex - Ohmeda, Inc. | Snap sensor connector | 
| WO2002069983A1              (en) | 2001-03-01 | 2002-09-12 | Bharat Serums & Vaccines Ltd. | Amphotericin b aqueous composition | 
| WO2002076344A1              (en) | 2001-03-23 | 2002-10-03 | Durect Corporation | Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space | 
| WO2002085428A2              (en) | 2001-04-19 | 2002-10-31 | Microsolutions, Inc. | Implantable osmotic pump | 
| US7144863B2              (en) | 2001-06-01 | 2006-12-05 | Eli Lilly And Company | GLP-1 formulations with protracted time action | 
| US20020197185A1              (en) | 2001-06-20 | 2002-12-26 | Jamiolkowski Dennis D. | Antimicrobial coatings for medical devices | 
| US6514517B2              (en) | 2001-06-20 | 2003-02-04 | Ethicon, Inc. | Antimicrobial coatings for medical devices | 
| US20030045454A1              (en) | 2001-06-21 | 2003-03-06 | Franklin Okumu | Sustained release formulation | 
| US20030104063A1              (en) | 2001-06-22 | 2003-06-05 | Babcock Walter C. | Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers | 
| US7163688B2              (en) | 2001-06-22 | 2007-01-16 | Alza Corporation | Osmotic implant with membrane and membrane retention means | 
| US7163697B2              (en) | 2001-06-22 | 2007-01-16 | Johns Hopkins University School Of Medicine | Biodegradable polymer compositions, compositions and uses related thereto | 
| WO2003000230A1              (en) | 2001-06-22 | 2003-01-03 | Alza Corporation | Osmotic implant with membrane and membrane retention means | 
| US20030007992A1              (en) | 2001-06-22 | 2003-01-09 | Southern Biosystems, Inc. | Zero-order prolonged release coaxial implants | 
| US20030138403A1              (en) | 2001-06-29 | 2003-07-24 | Maxygen Aps | Interferon formulations | 
| WO2003007981A1              (en) | 2001-07-20 | 2003-01-30 | Intermune, Inc. | Methods of treating liver fibrosis | 
| WO2003011892A2              (en) | 2001-07-31 | 2003-02-13 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Glp-1 exendin-4 peptide analogs and uses thereof | 
| US7101843B2              (en) | 2001-08-23 | 2006-09-05 | Eli Lilly And Company | Glucagon-like peptide-1 analogs | 
| US20040198654A1              (en) | 2001-08-23 | 2004-10-07 | Wolfgang Glaesner | Glucagon-like peptide-1analogs | 
| WO2003020245A1              (en) | 2001-08-31 | 2003-03-13 | Alkermes Controlled Therapeutics Inc. Ii | Residual solvent extraction method and microparticles produced thereby | 
| US20030118660A1              (en) | 2001-08-31 | 2003-06-26 | Alkermes Controlled Therapeutics Inc. Ii | Residual solvent extraction method and microparticles produced thereby | 
| US7666835B2              (en) | 2001-09-07 | 2010-02-23 | Imperial Innovations Limited | Oxyntomodulin for preventing or treating excess weight | 
| WO2003024357A2              (en) | 2001-09-14 | 2003-03-27 | Martin Francis J | Microfabricated nanopore device for sustained release of therapeutic agent | 
| WO2003024503A2              (en) | 2001-09-17 | 2003-03-27 | Durect Corporation | Device and method for accurate delivery of an active agent | 
| US20060224145A1              (en) | 2001-09-17 | 2006-10-05 | Gillis Edward M | Device and method for accurate delivery of an active agent | 
| US8217001B2              (en) | 2001-09-24 | 2012-07-10 | Imperial Innovations Limited | Modification of feeding behavior | 
| US7459432B2              (en) | 2001-09-24 | 2008-12-02 | Imperial College Innovations Ltd. | Modification of feeding behavior | 
| US20040002442A1              (en) | 2001-10-05 | 2004-01-01 | Clark Pan | Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use | 
| US7041646B2              (en) | 2001-10-05 | 2006-05-09 | Bayer Pharmaceuticals Corporation | Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists | 
| WO2003030923A1              (en) | 2001-10-05 | 2003-04-17 | Intermune, Inc. | Method of treating hepatitis virus infection with a multiphasic interferon delivery profile | 
| US20030078618A1              (en) | 2001-10-19 | 2003-04-24 | Fey Kate E. | System and method for removing implanted devices | 
| US20030097121A1              (en) | 2001-10-24 | 2003-05-22 | Claude Jolly | Implantable fluid delivery apparatuses and implantable electrode | 
| US20040142902A1              (en) | 2001-11-08 | 2004-07-22 | Struijker- Boudier Harry A.J. | Implant dosage form and use thereof for the delivery of a cholosterol lowering agent | 
| US20070248572A1              (en) | 2001-11-09 | 2007-10-25 | Intarica Therapeutics, Inc. | Method for treating diseases with omega interferon | 
| WO2003041684A2              (en) | 2001-11-14 | 2003-05-22 | Alza Corporation | Injectable depot compositions and uses thereof | 
| WO2003041757A2              (en) | 2001-11-14 | 2003-05-22 | Alza Corporation | Catheter injectable depot compositions and uses thereof | 
| US20030157178A1              (en) | 2001-11-14 | 2003-08-21 | Guohua Chen | Injectable depot composition | 
| US7829109B2              (en) | 2001-11-14 | 2010-11-09 | Durect Corporation | Catheter injectable depot compositions and uses thereof | 
| US20030180364A1              (en) | 2001-11-14 | 2003-09-25 | Guohua Chen | Catheter injectable depot compositions and uses thereof | 
| US20030170289A1              (en) | 2001-11-14 | 2003-09-11 | Guohua Chen | Injectable depot compositions and uses thereof | 
| US20030191099A1              (en) | 2001-11-27 | 2003-10-09 | Schering Ag | 17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations | 
| US20030108608A1              (en) | 2001-12-12 | 2003-06-12 | Erik Laridon | Thermoplastic articles comprising silver-containing antimicrobials and high amounts of carboxylic acid salts for increased surface-available silver | 
| US20030135153A1              (en) | 2001-12-17 | 2003-07-17 | Charles Hagemeier | Drug implant injection device | 
| EP1323450A1              (en) | 2001-12-18 | 2003-07-02 | Risdon Pharma GmbH | Syringe device | 
| WO2003053400A1              (en) | 2001-12-19 | 2003-07-03 | Alza Corporation | Formulation & dosage form for the controlled delivery of therapeutic agents | 
| US7141547B2              (en) | 2001-12-21 | 2006-11-28 | Human Genome Sciences, Inc. | Albumin fusion proteins comprising GLP-1 polypeptides | 
| US8058233B2              (en) | 2002-01-10 | 2011-11-15 | Oregon Health And Science University | Modification of feeding behavior using PYY and GLP-1 | 
| US20040029784A1              (en) | 2002-01-22 | 2004-02-12 | Hathaway David R. | Methods and compositions for treating polycystic ovary syndrome | 
| WO2003066585A2              (en) | 2002-02-08 | 2003-08-14 | Alkermes Controlled Therapeutics, Inc. | Polymer-based compositions for sustained release | 
| US8231859B2              (en) | 2002-02-27 | 2012-07-31 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials | 
| US8277776B2              (en) | 2002-02-27 | 2012-10-02 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials | 
| US7790140B2              (en) | 2002-02-27 | 2010-09-07 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials, and methods of making and using the same | 
| US7635463B2              (en) | 2002-02-27 | 2009-12-22 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials | 
| US8257682B2              (en) | 2002-02-27 | 2012-09-04 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials | 
| US7589169B2              (en) | 2002-02-27 | 2009-09-15 | Pharmain Corporation | Compositions for treatment with glucagon-like peptide, and methods of making and using the same | 
| WO2003072113A1              (en) | 2002-02-28 | 2003-09-04 | Norbrook Laboratories Limited | Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound | 
| US20050118221A1              (en) | 2002-02-28 | 2005-06-02 | William Blakely | Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound | 
| WO2003072133A2              (en) | 2002-02-28 | 2003-09-04 | Norferm Da | Immunostimulatory agent comprising a biomass of methanotrophic bacterium | 
| US20030215515A1              (en) | 2002-04-11 | 2003-11-20 | Medimmune Vaccines, Inc. | Preservation of bioactive materials by spray drying | 
| US6960192B1              (en) | 2002-04-23 | 2005-11-01 | Insulet Corporation | Transcutaneous fluid delivery system | 
| US20030220617A1              (en) | 2002-05-22 | 2003-11-27 | C. Dickerson Co. | Safety needle introducer and universal needle protector for vascular access devices | 
| US20140163057A1              (en) | 2002-05-31 | 2014-06-12 | Titan Pharmaceuticals, Inc. | Implantable Polymeric Device for Sustained Release of Buprenorphine | 
| US7736665B2              (en) | 2002-05-31 | 2010-06-15 | Titan Pharmaceuticals, Inc. | Implantable polymeric device for sustained release of buprenorphine | 
| US7074423B2              (en) | 2002-06-17 | 2006-07-11 | Alza Corporation | Osmotic delivery system with early zero order push power engine | 
| US20030233101A1              (en) | 2002-06-17 | 2003-12-18 | Senorx, Inc. | Plugged tip delivery tube for marker placement | 
| US20040097906A1              (en) | 2002-06-17 | 2004-05-20 | Fereira Pamela J. | Osmotic delivery system with early zero order push power engine | 
| US20040001889A1              (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations | 
| US6939556B2              (en) | 2002-06-26 | 2005-09-06 | Alza Corporation | Minimally compliant, volume efficient piston for osmotic drug delivery systems | 
| WO2004002565A1              (en) | 2002-06-26 | 2004-01-08 | Alza Corporation | Minimally compliant, volume efficient piston for osmotic drug delivery systems | 
| US7112335B2              (en) | 2002-06-26 | 2006-09-26 | Alza Corporation | Minimally compliant, volume-efficient piston for osmotic drug delivery systems | 
| US20060014678A1              (en) | 2002-06-28 | 2006-01-19 | Imperial College Innovations Ltd. | Modification of feeding behavior | 
| US20040001689A1              (en) | 2002-06-28 | 2004-01-01 | Intel Corporation | System and method for improving audio during post-production of video recordings | 
| US20040024069A1              (en) | 2002-07-31 | 2004-02-05 | Guohua Chen | Injectable depot compositions and uses thereof | 
| US20040022859A1              (en) | 2002-07-31 | 2004-02-05 | Guohua Chen | Injectable multimodal polymer depot compositions and uses thereof | 
| WO2004026106A2              (en) | 2002-09-18 | 2004-04-01 | Allergan, Inc. | Methods and apparatus for delivery of ocular implants | 
| US20040215133A1              (en) | 2002-09-18 | 2004-10-28 | Allergan, Inc. | Apparatus for delivery of ocular implants | 
| WO2004034975A2              (en) | 2002-10-17 | 2004-04-29 | Alkermes Controlled Therapeutics, Inc. | Sustained release profile modification | 
| WO2004036186A2              (en) | 2002-10-17 | 2004-04-29 | Alkermes Controlled Therapeutics, Inc. Ii | Microencapsulation and sustained release of biologically active polypeptides | 
| WO2004035762A2              (en) | 2002-10-17 | 2004-04-29 | Alkermes Controlled Therapeutics, Inc. Ii | Microencapsulation and sustained release of biologically active polypeptides | 
| WO2004035754A2              (en) | 2002-10-17 | 2004-04-29 | Alkermes Controlled Therapeutics, Inc. Ii | Microencapsulation and sustained release of biologically active polypeptides | 
| US20040209801A1              (en) | 2002-10-22 | 2004-10-21 | Brand Stephen J. | Treatment of diabetes | 
| US20040151753A1              (en) | 2002-11-06 | 2004-08-05 | Guohua Chen | Controlled release depot formulations | 
| WO2004046338A2              (en) | 2002-11-20 | 2004-06-03 | North Shore-Long Island Jewish Research Institute | Use of hmgb polypeptides for increasing immune responses | 
| US20050009742A1              (en) | 2002-11-20 | 2005-01-13 | Goran Bertilsson | Compounds and methods for increasing neurogenesis | 
| US6969702B2              (en) | 2002-11-20 | 2005-11-29 | Neuronova Ab | Compounds and methods for increasing neurogenesis | 
| US7316680B2              (en) | 2002-11-21 | 2008-01-08 | Intarcia Therapeutics, Inc. | Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel | 
| US20040102762A1              (en) | 2002-11-21 | 2004-05-27 | Gilbert Scott Jay | Osmotic delivery device having a two-way valve and dynamically self-adjusting flow channel | 
| US7014636B2              (en) | 2002-11-21 | 2006-03-21 | Alza Corporation | Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel | 
| WO2004052336A2              (en) | 2002-12-10 | 2004-06-24 | Durect Corporation | High viscosity liquid controlled delivery system and medical or surgical device | 
| US20040266683A1              (en) | 2002-12-17 | 2004-12-30 | Hathaway David R | Prevention and treatment of cardiac arrhythmias | 
| US8398967B2              (en) | 2002-12-19 | 2013-03-19 | Intarcia Therapeutics, Inc. | Particle formulations for use in pharmaceutical compositions | 
| WO2004056338A2              (en) | 2002-12-19 | 2004-07-08 | Alza Corporation | Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device | 
| US20090087408A1              (en) | 2002-12-19 | 2009-04-02 | Intarcia Therapeutics, Inc. | Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device | 
| US20040224903A1              (en) | 2002-12-19 | 2004-11-11 | Stephen Berry | Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device | 
| US20080064636A1              (en) | 2003-01-10 | 2008-03-13 | Imperial College Innovations Limited | Modification of Feeding Behaviour | 
| US7825091B2              (en) | 2003-01-10 | 2010-11-02 | Imperial Innovations Limited | Modification of feeding behaviour | 
| US20040142867A1              (en) | 2003-01-14 | 2004-07-22 | Kiyomoto Oi | Stabilized proteinic preparation | 
| US20070149011A1              (en) | 2003-02-18 | 2007-06-28 | Medconx, Inc. | Male medical device electrical connector with engineered friction fit | 
| WO2004089335A2              (en) | 2003-03-31 | 2004-10-21 | Alza Corporation | Non-aqueous single phase vehicles and formulations utilizing such vehicles | 
| US20050008661A1              (en) | 2003-03-31 | 2005-01-13 | Fereira Pamela J. | Non-aqueous single phase vehicles and formulations utilizing such vehicles | 
| US20050276856A1              (en) | 2003-03-31 | 2005-12-15 | Fereira Pamela J | Non-aqueous single phase vehicles and formulations utilizing such vehicles | 
| US7207982B2              (en) | 2003-03-31 | 2007-04-24 | Alza Corporation | Osmotic pump with means for dissipating internal pressure | 
| US20050010196A1              (en) | 2003-03-31 | 2005-01-13 | Fereira Pamela J. | Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems | 
| US20040199140A1              (en)* | 2003-04-03 | 2004-10-07 | Rue Matthew L. | Implanting device and method of using same | 
| WO2004089458A1              (en) | 2003-04-03 | 2004-10-21 | Valera Pharmaceuticals, Inc. | Implanting device and method of using same | 
| US7214206B2              (en) | 2003-04-03 | 2007-05-08 | Valera Pharmaceuticals, Inc. | Implanting device and method of using same | 
| US20050079200A1              (en) | 2003-05-16 | 2005-04-14 | Jorg Rathenow | Biocompatibly coated medical implants | 
| WO2004103342A2              (en) | 2003-05-16 | 2004-12-02 | Alkermes Controlled Therapeutics, Inc. | Injectable sustained release compositions | 
| US20050079202A1              (en) | 2003-05-30 | 2005-04-14 | Guohua Chen | Implantable elastomeric depot compositions and uses thereof | 
| US20050215475A1              (en) | 2003-05-30 | 2005-09-29 | John Ong | Transmucosal delivery of peptides and proteins | 
| US20060178304A1              (en) | 2003-06-03 | 2006-08-10 | Novo Nordisk A/S | Stabilized pharmaceutical peptide compositions | 
| US20050004557A1              (en) | 2003-06-12 | 2005-01-06 | Russell Scott M. | Orifice device having multiple channels with varying flow rates for drug delivery | 
| US20050010942A1              (en) | 2003-07-09 | 2005-01-13 | Samsung Electronics Co., Ltd. | Optical disc drive | 
| US20080260838A1              (en) | 2003-08-01 | 2008-10-23 | Mannkind Corporation | Glucagon-like peptide 1 (glp-1) pharmaceutical formulations | 
| US7205409B2              (en) | 2003-09-04 | 2007-04-17 | Abbott Laboratories | Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) | 
| US7241457B2              (en) | 2003-09-30 | 2007-07-10 | Alza Corporation | Osmotically driven active agent delivery device providing an ascending release profile | 
| US7407499B2              (en) | 2003-10-31 | 2008-08-05 | Intarcia Therapeutics, Inc. | Osmotic pump with self-retaining, fast-start membrane plug | 
| US20050095284A1              (en) | 2003-10-31 | 2005-05-05 | Alza Corporation | Osmotic pump with self-retaining, fast-start membrane plug | 
| US20050101943A1              (en) | 2003-11-06 | 2005-05-12 | Alza Corporation | Modular imbibition rate reducer for use with implantable osmotic pump | 
| US20050106214A1              (en) | 2003-11-14 | 2005-05-19 | Guohua Chen | Excipients in drug delivery vehicles | 
| US20050281879A1              (en) | 2003-11-14 | 2005-12-22 | Guohua Chen | Excipients in drug delivery vehicles | 
| US20050118206A1              (en) | 2003-11-14 | 2005-06-02 | Luk Andrew S. | Surfactant-based gel as an injectable, sustained drug delivery vehicle | 
| WO2005048930A2              (en) | 2003-11-14 | 2005-06-02 | Alza Corporation | Surfactant-based gel as an injectable, sustained drug delivery vehicle | 
| US7731947B2              (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle | 
| US20130052237A1              (en) | 2003-11-17 | 2013-02-28 | Intarcia Therapeutics, Inc. | Methods of Manufacturing Viscous Liquid Pharmaceutical Formulations | 
| WO2005048952A2              (en) | 2003-11-17 | 2005-06-02 | Alza Corporation | Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle | 
| US8257691B2              (en) | 2003-11-17 | 2012-09-04 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising a particle formulation and suspending vehicle | 
| US20050112188A1              (en) | 2003-11-17 | 2005-05-26 | Eliaz Rom E. | Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle | 
| US20170319470A1              (en) | 2003-11-17 | 2017-11-09 | Intarcia Therapeutics, Inc. | Methods of manufacturing viscous liquid pharmaceutical formulations | 
| US7964183B2              (en) | 2003-11-17 | 2011-06-21 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising a particle formulation and suspending vehicle | 
| US20050131386A1              (en) | 2003-12-15 | 2005-06-16 | Freeman Lynetta J. | Method and device for minimally invasive implantation of biomaterial | 
| US20050143749A1              (en) | 2003-12-31 | 2005-06-30 | Depuy Spine, Inc. | Inserter instrument and implant clip | 
| US20050175701A1              (en) | 2004-02-10 | 2005-08-11 | Alza Corporation | Capillary moderator for osmotic delivery system | 
| US20060094652A1              (en) | 2004-02-11 | 2006-05-04 | Levy Odile E | Hybrid polypeptides with selectable properties | 
| US20060293232A1              (en) | 2004-02-11 | 2006-12-28 | Amylin Pharmaceuticals, Inc. | Hybrid polypeptides with selectable properties | 
| US8722037B2              (en) | 2004-03-19 | 2014-05-13 | Meck Sharp & Dohme B.V. | X-ray visible drug delivery device | 
| US20070141102A1              (en) | 2004-03-24 | 2007-06-21 | N.V. Organon | Drug delivery system based on polyethylene vinylacetate copolymers | 
| US20050271702A1              (en) | 2004-04-15 | 2005-12-08 | Wright Steven G | Polymer-based sustained release device | 
| US7456254B2              (en) | 2004-04-15 | 2008-11-25 | Alkermes, Inc. | Polymer-based sustained release device | 
| US7612176B2              (en) | 2004-04-15 | 2009-11-03 | Alkermes, Inc. | Polymer-based sustained release device | 
| EP2133073A1              (en) | 2004-04-15 | 2009-12-16 | Amylin Pharmaceuticals, Inc. | Poly(lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar | 
| US7563871B2              (en) | 2004-04-15 | 2009-07-21 | Alkermes, Inc. | Polymer-based sustained release device | 
| WO2005110425A1              (en) | 2004-04-15 | 2005-11-24 | Alkermes, Inc. | Polymer-based sustained release device | 
| US20070166352A1              (en) | 2004-04-15 | 2007-07-19 | Alkermes, Inc. | Polymer-based sustained release device | 
| US20090247463A1              (en) | 2004-04-15 | 2009-10-01 | Alkermes, Inc. | Polymer-based sustained release device | 
| WO2005102293A1              (en) | 2004-04-15 | 2005-11-03 | Amylin Pharmaceuticals, Inc. | Poly (lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar | 
| US20080112994A1              (en) | 2004-05-25 | 2008-05-15 | Intarcia Therapeutics, Inc. | Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium | 
| US20050266087A1              (en) | 2004-05-25 | 2005-12-01 | Gunjan Junnarkar | Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium | 
| EP1600187B1              (en) | 2004-05-27 | 2009-01-21 | Cordis Corporation | Orifice device having multiple channels with varying flow rates for drug delivery | 
| US20090042781A1              (en) | 2004-06-28 | 2009-02-12 | Novo Nordisk A/S | Methods for Treating Diabetes | 
| WO2006017772A1              (en) | 2004-08-05 | 2006-02-16 | Alza Corporation | Stable suspension formulations of erythropoietin receptor agonists | 
| US20060030526A1              (en) | 2004-08-05 | 2006-02-09 | Kui Liu | Stable suspension formulations of erythropoietin receptor agonists | 
| WO2006023526A2              (en) | 2004-08-18 | 2006-03-02 | Waters Investments Limited | Defined leak path for high pressure seal | 
| US20080110515A1              (en) | 2004-08-18 | 2008-05-15 | Waters Investments Limited | Defined Lead Path For High Pressure Seal | 
| US20090163447A1              (en) | 2004-08-25 | 2009-06-25 | Maggio Edward T | Compositions for Drug Administration | 
| US20060094693A1              (en) | 2004-09-21 | 2006-05-04 | Point Therapeutics, Inc. | Methods and compositions for treating glucose-associated conditions, metabolic syndrome, dyslipidemias and other conditions | 
| US20080038316A1              (en) | 2004-10-01 | 2008-02-14 | Wong Vernon G | Conveniently implantable sustained release drug compositions | 
| US20060073182A1              (en) | 2004-10-01 | 2006-04-06 | Wong Vernon G | Conveniently implantable sustained release drug compositions | 
| US20060084604A1              (en) | 2004-10-19 | 2006-04-20 | Chieko Kitaura | Transepithelial delivery of peptides with incretin hormone activities | 
| US7442682B2              (en) | 2004-10-19 | 2008-10-28 | Nitto Denko Corporation | Transepithelial delivery of peptides with incretin hormone activities | 
| US7604647B2              (en) | 2004-10-22 | 2009-10-20 | Medical Instrument Development Laboratories, Inc. | Ophthalmic cannula insertion tool and method | 
| US20090156474A1              (en) | 2004-11-01 | 2009-06-18 | Amylin Pharmaceuticals, Inc. | Methods for treating obesity and obesity related diseases and disorders | 
| US20080207512A1              (en) | 2004-11-01 | 2008-08-28 | Amylin Pharmaceuticals, Inc. | Methods for Treating Obesity and Obesity Related and Disorders | 
| US20060142234A1              (en) | 2004-12-23 | 2006-06-29 | Guohua Chen | Injectable non-aqueous suspension | 
| US20060141040A1              (en) | 2004-12-23 | 2006-06-29 | Guohua Chen | Injectable non-aqueous suspension | 
| US20060160736A1              (en) | 2004-12-30 | 2006-07-20 | Diakine Therapeutics, Inc. | Pharmaceutical compositions and methods for restoring beta-cell mass and function | 
| US7393827B2              (en) | 2004-12-30 | 2008-07-01 | Diakine Therapeutics, Inc. | Pharmaceutical compositions and methods for restoring β-cell mass and function | 
| USD608447S1              (en)* | 2005-01-14 | 2010-01-19 | Edwards Lifesciences Corporation | Sensor case | 
| US20100298807A1              (en) | 2005-01-24 | 2010-11-25 | Akzo Nobel N.V. | Applicator for inserting an implant | 
| WO2006077250A1              (en) | 2005-01-24 | 2006-07-27 | N.V. Organon | Applicator for inserting an implant | 
| WO2006077242A1              (en) | 2005-01-24 | 2006-07-27 | N.V. Organon | Applicator for inserting an implant | 
| US8888745B2              (en) | 2005-01-24 | 2014-11-18 | Merck Sharp & Dohme B.V. | Applicator for inserting an implant | 
| WO2006081279A2              (en) | 2005-01-25 | 2006-08-03 | Microchips, Inc. | Control of drug release by transient modification of local microenvironments | 
| TW200634060A              (en) | 2005-02-03 | 2006-10-01 | Alza Corp | Solvent/polymer solutions as suspension vehicles | 
| US9526763B2              (en) | 2005-02-03 | 2016-12-27 | Intarcia Therapeutics Inc. | Solvent/polymer solutions as suspension vehicles | 
| US20170368145A1              (en) | 2005-02-03 | 2017-12-28 | Intarcia Therapeutics, Inc. | Osmotic delivery device comprising an insulinotropic peptide and uses thereof | 
| US20170348392A1              (en) | 2005-02-03 | 2017-12-07 | Intarcia Therapeutics Inc. | Solvent/polymer solutions as suspension vehicles | 
| WO2006084139A2              (en) | 2005-02-03 | 2006-08-10 | Intarcia Therapeutics, Inc. | An implantable interferon-containing device | 
| US8273365B2              (en) | 2005-02-03 | 2012-09-25 | Intarcia Therapeutics, Inc. | Two-piece, internal-channel osmotic delivery system flow modulator | 
| WO2006083761A2              (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles | 
| US8470353B2              (en) | 2005-02-03 | 2013-06-25 | Intarcia Therapeutics, Inc. | Two-piece, internal-channel osmotic delivery system flow modulator | 
| US8992962B2              (en) | 2005-02-03 | 2015-03-31 | Intarcia Therapeutics Inc. | Two-piece, internal-channel osmotic delivery system flow modulator | 
| US20120178687A1              (en) | 2005-02-03 | 2012-07-12 | Intarcia Therapeutics, Inc. | Suspension formulations of insulinotropic peptides and uses thereof | 
| US20170181964A1              (en) | 2005-02-03 | 2017-06-29 | Intarcia Therapeutics Inc. | Two-piece, internal-channel osmotic delivery system flow modulator | 
| US8460694B2              (en) | 2005-02-03 | 2013-06-11 | Intarcia Therapeutics, Inc. | Solvent/polymer solutions as suspension vehicles | 
| US7655254B2              (en) | 2005-02-03 | 2010-02-02 | Intarcia Therapeutics, Inc. | Implantable device for continuous delivery of interferon | 
| US8211467B2              (en) | 2005-02-03 | 2012-07-03 | Intarcia Therapeutics, Inc. | Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles | 
| US20060263433A1              (en) | 2005-02-03 | 2006-11-23 | Ayer Rupal A | Suspension formulation of interferon | 
| US8440226B2              (en) | 2005-02-03 | 2013-05-14 | Intarcia Therapeutics, Inc. | Solvent/polymer solutions as suspension vehicles | 
| US9682127B2              (en) | 2005-02-03 | 2017-06-20 | Intarcia Therapeutics, Inc. | Osmotic delivery device comprising an insulinotropic peptide and uses thereof | 
| US8206745B2              (en) | 2005-02-03 | 2012-06-26 | Intarcia Therapeutics, Inc. | Solvent/polymer solutions as suspension vehicles | 
| US20170056476A1              (en) | 2005-02-03 | 2017-03-02 | Intarcia Therapeutics Inc. | Solvent/polymer solutions as suspension vehicles | 
| US9539200B2              (en) | 2005-02-03 | 2017-01-10 | Intarcia Therapeutics Inc. | Two-piece, internal-channel osmotic delivery system flow modulator | 
| US20070281024A1              (en) | 2005-02-03 | 2007-12-06 | Alza Corporation | Two-Piece, Internal-Channel Osmotic Delivery System Flow Modulator | 
| US20060216242A1              (en) | 2005-02-03 | 2006-09-28 | Rohloff Catherine M | Suspending vehicles and pharmaceutical suspensions for drug dosage forms | 
| US8158150B2              (en) | 2005-02-03 | 2012-04-17 | Intarcia Therapeutics, Inc. | Two-piece, internal-channel osmotic delivery system flow modulator | 
| US8114437B2              (en) | 2005-02-03 | 2012-02-14 | Intarcia Therapeutics, Inc. | Solvent/polymer solutions as suspension vehicles | 
| US8052996B2              (en) | 2005-02-03 | 2011-11-08 | Intarcia Therapeutics, Inc. | Two-piece, internal-channel osmotic delivery system flow modulator | 
| US20110264077A1              (en) | 2005-02-03 | 2011-10-27 | Intarcia Therapeutics, Inc. | Solvent/polymer solutions as suspension vehicles | 
| US8940316B2              (en) | 2005-02-03 | 2015-01-27 | Intarcia Therapeutics, Inc. | Osmotic delivery comprising an insulinotropic peptide and uses thereof | 
| US9095553B2              (en) | 2005-02-03 | 2015-08-04 | Intarcia Therapeutics Inc. | Solvent/polymer solutions as suspension vehicles | 
| US20060193918A1              (en) | 2005-02-03 | 2006-08-31 | Rohloff Catherine M | Solvent/polymer solutions as suspension vehicles | 
| US8299025B2              (en) | 2005-02-03 | 2012-10-30 | Intarcia Therapeutics, Inc. | Suspension formulations of insulinotropic peptides and uses thereof | 
| US20150231062A1              (en) | 2005-02-03 | 2015-08-20 | Intarcia Therapeutics Inc. | Two-piece, internal-channel osmotic delivery system flow modulator | 
| US20080260840A1              (en) | 2005-02-03 | 2008-10-23 | Alessi Thomas R | Suspension formulations of insulinotropic peptides and uses thereof | 
| US20100297209A1              (en) | 2005-02-03 | 2010-11-25 | Intarcia Therapeutics, Inc. | Solvent/polymer solutions as suspension vehicles | 
| US20130034210A1              (en) | 2005-02-03 | 2013-02-07 | Intarcia Therapeutics, Inc. | Solvent/polymer solutions as suspension vehicles | 
| US20110104111A1              (en) | 2005-02-03 | 2011-05-05 | Intarcia Therapeutics, Inc. | Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles | 
| US20060251618A1              (en) | 2005-02-03 | 2006-11-09 | Paula Dennis | Implantable device for continuous delivery of interferon | 
| US8367095B2              (en) | 2005-02-03 | 2013-02-05 | Intarcia Therapeutics, Inc. | Two-piece, internal-channel osmotic delivery system flow modulator | 
| WO2006086727A2              (en) | 2005-02-09 | 2006-08-17 | Entelos, Inc. | Treating diabetes with glucagon-like peptide-1 secretagogues | 
| US20090286723A1              (en) | 2005-02-11 | 2009-11-19 | Amylin Pharmaceuticals, Inc. | Hybrid Polypeptides with Selectable Properties | 
| US8263545B2              (en) | 2005-02-11 | 2012-09-11 | Amylin Pharmaceuticals, Inc. | GIP analog and hybrid polypeptides with selectable properties | 
| US20080312157A1              (en) | 2005-02-11 | 2008-12-18 | Amylin Pharmaceuticals, Inc. | Gip analog and hybrid polypeptides with selectable properties | 
| US20090036364A1              (en) | 2005-02-11 | 2009-02-05 | Amylin Pharmaceuticals, Inc. | Gip analog and hybrid polypeptides with selectable properties | 
| US8202836B2              (en) | 2005-03-09 | 2012-06-19 | Imperial Innovations Limited | Modified PYY (3-36) peptides and their effects on feeding behavior | 
| US8114430B2              (en) | 2005-03-15 | 2012-02-14 | Intarcia Therapeutics, Inc. | Polyoxaester suspending vehicles for use with implantable delivery systems | 
| US20060246138A1              (en) | 2005-03-15 | 2006-11-02 | Rohloff Catherine M | Polyoxaester suspending vehicles for use with implantable delivery systems | 
| WO2006101815A2              (en) | 2005-03-15 | 2006-09-28 | Alza Corporation | Pharmaceutical compositions comprising polyoxaester and active agents for use with osmotic delivery systems | 
| US7959938B2              (en) | 2005-03-15 | 2011-06-14 | Intarcia Therapeutics, Inc. | Polyoxaester suspending vehicles for use with implantable delivery systems | 
| US7879794B2              (en) | 2005-03-31 | 2011-02-01 | Amylin Pharmaceuticals, Inc. | Methods for controlling binge eating disorders | 
| US8278267B2              (en) | 2005-03-31 | 2012-10-02 | Amylin Pharmaceuticals, Llc | Method of modifying food preference comprising administering amylin or amylin agonist | 
| US20080200383A1              (en) | 2005-04-08 | 2008-08-21 | Amylin Pharmaceuticals, Inc. | Pharmaceutical Formulations Comprising Incretin Peptide and Aprotic Polar Solvent | 
| WO2006111169A1              (en) | 2005-04-21 | 2006-10-26 | Gastrotech Pharma A/S | Pharmaceutical preparations of a glp-1 molecule and an anti-emetic drug | 
| US20060264890A1              (en) | 2005-05-06 | 2006-11-23 | Medtronic Minimed, Inc. | Needle inserter and method for infusion device | 
| WO2006131730A1              (en) | 2005-06-06 | 2006-12-14 | Camurus Ab | Glp-1 analogue formulations | 
| US20060280795A1              (en) | 2005-06-08 | 2006-12-14 | Dexcel Pharma Technologies, Ltd. | Specific time-delayed burst profile delivery system | 
| US20080269725A1              (en) | 2005-07-22 | 2008-10-30 | Trent Deem | Osmotically Driven Dispense Pump and Related Components for Use in High Pressure Applications | 
| US20070027105A1              (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle | 
| WO2007024700A2              (en) | 2005-08-19 | 2007-03-01 | Amylin Pharmaceuticals, Inc. | Exendin for treating diabetes and reducing body weight | 
| US20090312246A1              (en) | 2005-08-19 | 2009-12-17 | Amylin Pharmaceuticals, Inc. | Uses of Glucoregulatory Proteins | 
| WO2007056681A2              (en) | 2005-11-04 | 2007-05-18 | Smithkline Beecham Corporation | Methods for administering hypoglycemic agents | 
| US8039432B2              (en) | 2005-11-09 | 2011-10-18 | Conjuchem, Llc | Method of treatment of diabetes and/or obesity with reduced nausea side effect | 
| US20070207958A1              (en) | 2005-11-09 | 2007-09-06 | Bridon Dominique P | Method of treatment of diabetes and/or obesity with reduced nausea side effect | 
| US20090209460A1              (en) | 2005-12-16 | 2009-08-20 | Amylin Pharmaceuticals, Inc. | Compositions and methods for treating obesity and related metabolic disorders | 
| WO2007075534A2              (en) | 2005-12-16 | 2007-07-05 | Nektar Therapeutics Al, Corporation | Polymer conjugates of glp-1 | 
| WO2007084460A2              (en) | 2006-01-18 | 2007-07-26 | Qps, Llc | Pharmaceutical compositions with enhanced stability | 
| WO2007082889A1              (en) | 2006-01-19 | 2007-07-26 | N.V. Organon | Kit for and method of assembling an applicator for inserting an implant | 
| US20090012463A1              (en) | 2006-01-19 | 2009-01-08 | N.V. Organon | Kit for and method of assembling an applicator for inserting an implant | 
| US20090186817A1              (en) | 2006-03-21 | 2009-07-23 | Amylin Pharmaceuticals, Inc. | Peptide-peptidase inhibitor conjugates and methods of using same | 
| US20090074734A1              (en) | 2006-05-02 | 2009-03-19 | Actogenix N.V. | Microbial intestinal delivery of obesity related peptides | 
| WO2007133778A2              (en) | 2006-05-12 | 2007-11-22 | Amylin Pharmaceuticals, Inc. | Methods to restore glycemic control | 
| WO2007140416A2              (en) | 2006-05-30 | 2007-12-06 | Intarcia Therapeutics, Inc. | Two-piece, internal-channel osmotic delivery system flow modulator | 
| EP2020990B1              (en) | 2006-05-30 | 2010-09-22 | Intarcia Therapeutics, Inc | Two-piece, internal-channel osmotic delivery system flow modulator | 
| US8263736B2              (en) | 2006-07-03 | 2012-09-11 | Imperial Innovations Limited | Compounds and their effects on feeding behaviour | 
| US20080020016A1              (en) | 2006-07-11 | 2008-01-24 | Quest Pharmaceutical Services, Llc | Pharmaceutical compositions for sustained release delivery of peptides | 
| US20100144621A1              (en) | 2006-08-04 | 2010-06-10 | Dennis Kim | Use of Exendins and Exendin Agonists and GLP-1 Receptor Agonists for Altering the Concentration of Fibrinogen | 
| US20100185184A1              (en) | 2006-08-09 | 2010-07-22 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies for use therein | 
| US20080091176A1              (en) | 2006-08-09 | 2008-04-17 | Alessi Thomas R | Osmotic delivery systems and piston assemblies for use therein | 
| US7879028B2              (en) | 2006-08-09 | 2011-02-01 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies for use therein | 
| WO2008021133A2              (en) | 2006-08-09 | 2008-02-21 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies | 
| US20110166554A1              (en) | 2006-08-09 | 2011-07-07 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies for use therein | 
| US20140378900A1              (en) | 2006-08-09 | 2014-12-25 | Intarcia Therapeutics, Inc. | Osmotic Delivery Systems and Piston Assemblies for Use Therein | 
| US8801700B2              (en) | 2006-08-09 | 2014-08-12 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies for use therein | 
| US7682356B2              (en) | 2006-08-09 | 2010-03-23 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies for use therein | 
| WO2008041245A2              (en) | 2006-10-05 | 2008-04-10 | Panacea Biotec Ltd. | Injectable depot composition and it's process of preparation | 
| US8845726B2              (en)* | 2006-10-18 | 2014-09-30 | Vertiflex, Inc. | Dilator | 
| US20090125030A1              (en)* | 2006-10-18 | 2009-05-14 | Shawn Tebbe | Dilator | 
| US7632256B2              (en) | 2006-10-24 | 2009-12-15 | Mosler Theodore J | Catheter gripping device | 
| WO2008061355A1              (en) | 2006-11-24 | 2008-05-29 | Matregen Corp. | Glp-1 depot systems, and methods of manufacture and uses thereof | 
| US8101576B2              (en) | 2006-12-13 | 2012-01-24 | Imperial Innovations Limited | Compounds and their effects on feeding behaviour | 
| WO2008086086A2              (en) | 2007-01-05 | 2008-07-17 | Indiana University Research And Technology Corporation | Glucagon analogs exhibiting enhanced solubility in physiological ph buffers | 
| USD555589S1              (en)* | 2007-01-23 | 2007-11-20 | Intec, Inc. | Battery charger and game controller cradle | 
| US20090022727A1              (en) | 2007-01-26 | 2009-01-22 | Alza Corp. | Injectable, nonaqueous suspension with high concentration of therapeutic agent | 
| US20080208194A1              (en)* | 2007-02-13 | 2008-08-28 | Christine Bickenbach | Double cut shaver | 
| WO2008133908A2              (en) | 2007-04-23 | 2008-11-06 | Intarcia Therapeutics, Inc. | Suspension formulations of insulinotropic peptides and uses thereof | 
| US8556861B2              (en)* | 2007-04-23 | 2013-10-15 | Sid Technologies, Llc | Methods and devices for intradermal injection | 
| WO2008134425A1              (en) | 2007-04-27 | 2008-11-06 | Cedars-Sinai Medical Center | Use of glp-1 receptor agonists for the treatment of gastrointestinal disorders | 
| US20090202481A1              (en) | 2008-02-08 | 2009-08-13 | Qps Llc | Composition for Sustained Release Delivery of Proteins or Peptides | 
| US20150111818A1              (en) | 2008-02-13 | 2015-04-23 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents | 
| US20090202608A1              (en) | 2008-02-13 | 2009-08-13 | Alessi Thomas R | Devices, formulations, and methods for delivery of multiple beneficial agents | 
| US8343140B2              (en) | 2008-02-13 | 2013-01-01 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents | 
| US9572889B2              (en) | 2008-02-13 | 2017-02-21 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents | 
| US8926595B2              (en) | 2008-02-13 | 2015-01-06 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents | 
| US20170079906A1              (en) | 2008-02-13 | 2017-03-23 | Intarcia Therapeutics Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents | 
| US20090210019A1              (en) | 2008-02-14 | 2009-08-20 | Dennis Dong-Won Kim | Treatment of excess weight by neural downregulation in combination with compositions | 
| WO2009109927A2              (en) | 2008-03-05 | 2009-09-11 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer | 
| US20090234392A1              (en) | 2008-03-13 | 2009-09-17 | Depuy Spine, Inc. | Method for inserting a spinal fixation element using implants having guide tabs | 
| US20090254143A1              (en) | 2008-04-04 | 2009-10-08 | Tweden Katherine S | Methods and systems for glucose regulation | 
| WO2009143285A2              (en) | 2008-05-21 | 2009-11-26 | Amylin Pharmaceuticals, Inc. | Exendins to lower cholestrol and triglycerides | 
| US20100105627A1              (en) | 2008-09-17 | 2010-04-29 | Paul Salama | Pharmaceutical compositions and related methods of delivery | 
| US20160030337A1              (en) | 2008-09-30 | 2016-02-04 | Braeburn Pharmaceuticals Bvba Sprl | Implantable device for the delivery of risperidone and methods of use thereof | 
| US9078900B2              (en) | 2008-09-30 | 2015-07-14 | Braeburn Pharmaceuticals Bvba Sprl | Implantable device for the delivery of risperidone and methods of use thereof | 
| US20100094252A1              (en) | 2008-10-14 | 2010-04-15 | Medtronic, Inc. | Subcutaneous delivery tool | 
| WO2010045169A1              (en) | 2008-10-14 | 2010-04-22 | Medtronic, Inc. | Subcutaneous delivery tool | 
| US20100092566A1              (en) | 2008-10-15 | 2010-04-15 | Alessi Thomas R | Highly concentrated drug particles, formulations, suspensions and uses thereof | 
| NZ592113A              (en) | 2008-10-15 | 2012-04-27 | Intarcia Therapeutics Inc | Highly concentrated drug particles, formulations, suspensions and uses thereof | 
| US20170119854A1              (en) | 2008-10-15 | 2017-05-04 | Intarcia Therapeutics, Inc. | Highly concentrated drug particles, formulations, suspensions and uses thereof | 
| US20160022582A1              (en) | 2008-10-15 | 2016-01-28 | Intarcia Therapeutics, Inc. | Highly concentrated drug particles, formulations, suspensions and uses thereof | 
| USD638478S1              (en)* | 2009-07-06 | 2011-05-24 | Performance Designed Products Llc | Video game controller accessory | 
| US8858621B2              (en)* | 2009-07-23 | 2014-10-14 | Edwards Lifesciences Corporation | Methods of implanting a prosthetic heart valve | 
| USD810289S1              (en)* | 2009-09-14 | 2018-02-13 | Bayer Oy | Inserter | 
| US20110076317A1              (en) | 2009-09-28 | 2011-03-31 | Alessi Thomas R | Rapid establishment and/or termination of substantial steady-state drug delivery | 
| US20130030417A1              (en) | 2009-09-28 | 2013-01-31 | Intarcia Therapeutics, Inc. | Rapid Establishment and/or Termination of Substantial Steady-State Drug Delivery | 
| US8298561B2              (en) | 2009-09-28 | 2012-10-30 | Intarcia Therapeutics, Inc. | Rapid establishment and/or termination of substantial steady-state drug delivery | 
| US20160354305A1              (en) | 2009-09-28 | 2016-12-08 | Intarcia Therapeutics, Inc. | Rapid establishment and/or termination of substantial steady-state drug delivery | 
| US20120265232A1              (en)* | 2009-10-23 | 2012-10-18 | Andrea Surbone | Guide tube for tattoo machine needles | 
| US8815802B2              (en) | 2009-12-16 | 2014-08-26 | Novo Nordisk A/S | GLP-1 analogues and derivatives | 
| US20110152182A1              (en) | 2009-12-22 | 2011-06-23 | Eli Lilly And Company | Oxyntomodulin peptide analogue | 
| US20110152181A1              (en) | 2009-12-22 | 2011-06-23 | Eli Lilly And Company | Oxyntomodulin peptide analogue | 
| US20110306549A1              (en) | 2010-06-09 | 2011-12-15 | Amylin Pharmaceuticals, Inc. | Glp-1 receptor agonists to treat pancreatitis | 
| USD669589S1              (en) | 2010-08-31 | 2012-10-23 | Koninklijke Philips Electronics N.V. | Blood system cartridge | 
| US8747412B2              (en) | 2011-02-14 | 2014-06-10 | Imds Corporation | System and method for bone anchor removal | 
| US20170252409A1              (en) | 2011-02-16 | 2017-09-07 | Intarcia Therapeutics, Inc. | Compositions, devices and methods of use thereof for the treatment of cancers | 
| US20120208755A1              (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers | 
| US20150057227A1              (en) | 2011-02-16 | 2015-02-26 | Intarcia Therapeutics, Inc. | Compositions, devices and methods of use thereof for the treatment of cancers | 
| US20120303045A1              (en) | 2011-05-26 | 2012-11-29 | Derm Instruments & Innovations Llc | Skin removal instrument | 
| WO2013004983A1              (en) | 2011-07-04 | 2013-01-10 | Imperial Innovations Limited | Novel compounds and their effects on feeding behaviour | 
| USD678889S1              (en)* | 2011-10-04 | 2013-03-26 | Avision Inc. | Scanner docking station | 
| US20140058409A1              (en) | 2012-04-19 | 2014-02-27 | Removaid As | Device for removing an item implanted underneath the skin | 
| GB2501400A              (en) | 2012-04-19 | 2013-10-23 | Removaid As | Tool for removing a subcutaneous implant | 
| US20130296661A1              (en) | 2012-05-04 | 2013-11-07 | Pacesetter, Inc. | System and method for implanting a physiologic sensor assembly | 
| US20130324977A1              (en) | 2012-06-04 | 2013-12-05 | Medtronic, Inc. | Transcutaneous implant tools, systems and methods | 
| WO2013184235A1              (en) | 2012-06-04 | 2013-12-12 | Medtronic, Inc. | Transcutaneous implant tools, systems and methods | 
| USD805199S1              (en)* | 2012-06-21 | 2017-12-12 | Importla, Llc | Tattoo tube | 
| US9332995B2              (en) | 2012-09-25 | 2016-05-10 | Russo Inventions, Llc | Bone-harvesting tool | 
| US9241722B2              (en)* | 2012-10-08 | 2016-01-26 | Warsaw Orthopedic, Inc. | Surgical pin guide and methods of use | 
| US20150297509A1              (en) | 2012-11-19 | 2015-10-22 | Braeburn Pharmaceuticals Bvba Sprl | Implantable drug delivery compositions and methods of treatment thereof | 
| US20140148837A1              (en)* | 2012-11-28 | 2014-05-29 | Richard M. Levitan | Surgical device for cricothyrotomy and the like | 
| US20140324067A1              (en)* | 2013-01-09 | 2014-10-30 | Senseonics, Incorporated | Subcutaneous tunneling and implantation tools for a disk-shaped sensor | 
| US20140236162A1              (en) | 2013-02-19 | 2014-08-21 | Mark Barongan | Apparatus for Removing Devices Implanted in the Body | 
| USD750764S1              (en)* | 2014-04-08 | 2016-03-01 | Bootz Manufacturing Company | Shower pan | 
| USRE46577E1              (en)* | 2014-06-05 | 2017-10-24 | Deka Products Limited Partnership | Enclosure for a peritoneal dialysis device | 
| US20150359553A1              (en) | 2014-06-16 | 2015-12-17 | Med-El Elektromedizinische Geraete Gmbh | Implant magnet insertion and removal tools | 
| US9889085B1              (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c | 
| USD819820S1              (en)* | 2015-04-24 | 2018-06-05 | Otto Bock Healthcare Products Gmbh | Part of prosthesis | 
| US20160354115A1              (en) | 2015-06-03 | 2016-12-08 | Intarcia Therapeutics, Inc. | Implant placement and removal systems | 
| USD789539S1              (en)* | 2015-07-09 | 2017-06-13 | Spinal Surgical Strategies, Llc | Fusion cage | 
| USD789540S1              (en)* | 2016-01-29 | 2017-06-13 | Veterinary Implants Direct, Llc. | Orthopedic plate | 
| US20170273706A1              (en)* | 2016-03-24 | 2017-09-28 | A.M. Surgical, Inc. | Compact endoscopic surgical device and method of use thereof | 
| US9931133B2              (en)* | 2016-03-24 | 2018-04-03 | A.M. Surgical, Inc. | Compact endoscopic surgical device and method of use thereof | 
| US20180009871A1              (en) | 2016-05-16 | 2018-01-11 | Intarcia Therapeutics Inc. | Glucagon-receptor selective polypeptides and methods of use thereof | 
| US20180193059A1              (en)* | 2017-01-10 | 2018-07-12 | Electronics And Telecommunications Research Institute | Automatic hair follicle transplant apparatus | 
| USD816843S1              (en)* | 2017-06-07 | 2018-05-01 | Alevio, Llc | Orthopedic implant |